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SCHEDULE AT A GLANCE 
 
Wednesday 11th August 2010 
 
14.30-17.30  Session 1: Gene Regulatory Networks I 
15.40-16.00  Break 
16.00-17.30  Session 1, continued 
17.30-18.30  Keynote Speaker: Charlie Boone          
18.30-19.30  Wine and Cheese Party 
19.30-21.00  Dinner    
 
Thursday 12th August  2010 
 
07.30-09.00  Breakfast 
09.00-10.40  Session 2: Protein-Protein Interaction Networks 
10.40-11:00  Morning Coffee 
11:00-12:30  Session 2, continued   
12.30-14.00  Lunch 
14.00-15.10  Session 3: Genetic Networks 
15.10-15.30  Break 
15.30-17.00  Session 3, continued  
17.00-19.00  Poster Session I 
19.00-21.00  Dinner                               
 
Friday 13th August  2010 
 
07.30-09.00  Breakfast 
09.00-10.40  Session 4: Network Medicine 
10.40-11.00  Morning Coffee 
11.00-12.30  Session 4, continued 
12.30-14.00  Lunch 
14.00-15.20  Session 5: Gene Regulatory Networks II 
15.20-15.40  Break 
15.40-17.10  Session 5, continued 
17.10-19.00  Poster Session II 
19.00-21.00  Dinner 
 
Saturday 14th August 2010 
 
07.30-09.00  Breakfast 
09.00-10.30  Session 6: Signalling Networks 
10.30-10.50  Morning Coffee 
10.50-12.20  Session 6, continued 
12.30-14.00  Lunch 
14.00-15.20  Session 7: Metabolic Networks 
15.20-15.40  Break 
15.40-16.40  Keynote Speaker: Edward Marcotte 
17.00-19.00  Pre-dinner Drinks 
19.00-21.00  Conference Dinner 
General Information 
 
Welcome to the Wellcome Trust Conference Centre and the Systems 
Biology: Networks Conference. 
 
Conference Badges 
Please wear your name badge at all times to promote networking and to 
assist staff in identifying you.    
 
If you have advised us of any dietary requirements, you will find a small 
coloured dot on your badge. Please make yourself known to the catering 
team and they will assist you with your meal request. 
 
Scientific Session Protocol 
Photography, audio or video recording of the scientific sessions is not 
permitted. 
 
Internet Access 
Wireless internet access is available throughout the campus. Please inquire 
at reception for a Wireless Connection token. 
 
Presentations 
If you are an invited speaker or your abstract has been selected for an oral 
presentation, please provide an electronic copy of you talk to a member of 
the AV team who will be based in the auditorium.  
 
Poster Sessions 
Posters will be displayed throughout the conference. Please post your 
materials in the Cloisters on arrival. The abstract page number indicates to 
the assigned poster board number 
 
Conference Meals 
All meals will be served in the Hall Restaurant.  Please refer to the 
conference programme in this book as times will vary based on the daily 
scientific presentations. 
 
Social Events 
The Hall Bar (cash bar) will be open from 19.00 – 23:00 each day. 
 
Wednesday, 11 August – A Wine and Cheese reception will take place in the 
Conference Centre Cloisters from 18.30-19.30  
 
Thursday, 12 August – A drinks reception will take place in the Conference 
Centre Cloisters from 17.00 during poster session I. 
 
Friday, 13 August – A drinks reception will take place in the Conference 
Centre Cloisters from 17.10 during poster session II. 
 
Saturday, 14 August – Pre dinner drinks will take place in the Conference 
Centre Cloisters from 17.00. 
 
All conference meals and social events are for registered delegates only. 
 
For Wellcome Trust Conference Centre Guests 
Check in 
If you are staying on site at the Wellcome Trust you may check into your 
room from 2.00pm. If you plan to arrive late at night you can check into your 
room as the conference centre reception is open 24 hours.  Please note 
there will be no lunch or dinner facilities available outside of the conference 
timetable; however, there is a local public house (The Red Lion), serving 
both lunch and evening meals, located just 2 minute walk from the campus 
in the village of Hinxton.    
 
Breakfast 
Your breakfast will be served in the Hall restaurant from 07.30 – 09.00 every 
morning. 
 
Telephone 
If you are staying on-site and would like to use the telephone in your room, 
you will need to contact the Reception desk (Ext. 5000) to have your phone 
line activated - we will require your credit card number and expiry date to do 
so.   
 
Departures 
You must vacate your room by 10.00 on the day of your departure.  Please 
ask at reception for assistance with luggage storage in the Conference 
Centre. 
 
Red Lion Public House Guests 
Check in 
If you are staying at the Red Lion Public House, you are able to check into 
your room from 13.00-15.00 or 18.00-23.00 
 
Breakfast 
Your breakfast will be served at the Red Lion from 07.30-08.30 Monday - 
Friday and 08.30-09.30 Saturday - Sunday. 
 
You must vacate your room by 10.30 on the day of your departure. A 
luggage store is available in the Conference Centre please ask at the 
reception. 
 
Return Ground Transportation 
Complimentary return transportation to Heathrow, Stansted Airport and the 
Cambridge Train Station and City Centre have been arranged for 09.30 on 
Sunday, 15 August. Please note: a sign-up sheet will be available at the 
registration desk.  Places are limited so you are advised to book early.        
 
Taxis 
Please find a list of local taxi numbers should you require: 
Panther – 01223 715715 
Mid Anglia - Tel: 01223 836000 
Phil's Taxi Services - Tel: 01223 521918 
A&M Carriages (Airport Specialist) - Tel: 01223 513703 
            
Messages and Miscellaneous 
All messages will be posted on the registration desk in the Conference 
Centre Foyer. 
 
A number of toiletry and stationery items are available for purchase at the 
conference centre reception.  Cards for our self-service laundry are also 
available.   
 
If you have any queries or comments, please do not hesitate to contact a 
member of staff who will be pleased to help you. 
Joint Cold Spring Harbor Laboratory/Wellcome Trust conferences 
at Hinxton are supported in part with funding courtesy of  
The Wellcome Trust. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
These abstracts should not be cited in bibliographies.  Material 
contained herein should be treated as personal communication and 
should be cited as such only with consent of the author. 
 
Printed on 100% recycled paper. 
 
 
 
 
Front Cover: The genetic landscape of a yeast cell as described by 
Costanzo et al., Science. 2010 Jan 22;327(5964):425-31.  The image was 
generated by Anastasia Baryshnikova.  
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PROGRAM 
 
 
WEDNESDAY, August 11—2:30 PM 
 
 
SESSION 1 GENE REGULATORY NETWORKS I 
 
Chairperson: L. Serrano, Centre for Genomic Regulation, Barcelona,  
  Spain 
 
 
Pascal Braun 
Presenter affiliation: Dana-Farber Cancer Institute. 
 
  
Protein-protein interaction network of post-transcriptional gene 
expression regulation in Trypanosoma cruzi 
Christian M. Probst, Henrique Preti, Daniela P. Pavoni, Fabricio K. 
Marchini, Newton M. Vidal, Marco A. Krieger. 
Presenter affiliation: Carlos Chagas Institute - ICC/FIOCRUZ, Curitiba, 
Brazil. 
 
 
 
 
 
1 
  
High-resolution transcriptome-wide identification of HuR 
regulatory elements 
Neelanjan Mukherjee, Jeff Nusbaum, David Corcoran, Uwe Ohler, 
Thomas Tuschl, Jack Keene. 
Presenter affiliation: Duke University Medical Center, Durham, North 
Carolina. 
 
 
 
 
 
2 
  
Individual variation in gene expression in genetic and network 
studies 
Renuka R. Nayak, Vivian G. Cheung. 
Presenter affiliation: Howard Hughes Medical Institute, University of 
Pennsylvania, Philadelphia, Pennsylvania. 
 
 
 
 
3 
  
Investigating the connection between the nuclear organization 
and the primary structure in senescent chromatin 
Tamir Chandra, Jean-Yves Thuret, Lixiang Xue, Rekin's Janky, 
Shamith A. Samarajiwa, Scott Newman, Masako Narita, Agustin 
Chicas, Paul A. Edwards, Madan M. Babu, Scott W. Lowe, Simon 
Tavare, Masashi Narita. 
Presenter affiliation: Cancer Research UK, Cambridge, United 
Kingdom. 
 
 
 
 
 
 
 
4 
  
 viii 
Transcription networks in the DNA damage stress response in ES 
cells 
R Siddappa, L von Stechow, J Carreras Puigvert, B van de Water, E 
H.J. Danen. 
Presenter affiliation: Leiden University/LACDR, Leiden, Netherlands. 
 
 
 
 
5 
  
IMEx—When the major molecular interaction databases 
collaborate together to serve you better 
Samuel Kerrien, The IMEx Consortium, Henning Hermjakob. 
Presenter affiliation: European Bioinformatics Institute, Hinxton, United 
Kingdom. 
 
 
 
 
6 
 
 
WEDNESDAY, August 11—5:30 PM 
 
 
KEYNOTE SPEAKER 
  
The genetic landscape of a cell 
Charles Boone 
Presenter affiliation: University of Toronto, Toronto, Canada. 
 
 
7 
 
 
 
WEDNESDAY, August 11—6:30 PM 
 
Wine and Cheese Party 
 
 
 
THURSDAY, August 12—9:00 AM 
 
 
SESSION 2 PROTEIN-PROTEIN INTERACTION NETWORKS 
 
Chairperson: V. Cheung, University of Pennsylvania, Philadelphia, USA 
 
  
Biochemical approaches to biomolecular networks 
Anne-Claude Gavin. 
Presenter affiliation: European Molecular Biology Laboratory, 
Heidelberg, Germany. 
 
 
 
8 
  
 ix 
A dynamic view of domain-motif interaction networks 
Hanah Margalit, Eyal Akiva. 
Presenter affiliation: The Hebrew University of Jerusalem, Jerusalem, 
Israel. 
 
 
 
9 
  
NetAligner—Fast and accurate alignment of protein interaction 
networks 
Roland A. Pache, Patrick Aloy. 
Presenter affiliation: Institute for Research in Biomedicine (IRB) 
Barcelona, Barcelona, Spain; Barcelona Supercomputing Center 
(BSC), Barcelona, Spain. 
 
 
 
 
 
10 
  
Transient complexes along protein-protein association 
Michal Harel, Gideon Schreiber. 
Presenter affiliation: Weizmann Institute of Science, Rehovot, Israel. 
 
 
11 
  
Systems biology analysis of a small bacterium—M. pneumoniae 
Luis F. Serrano. 
Presenter affiliation: Centro Regulacion Genomica, Barcelona, Spain. 
 
 
12 
  
From biological networks to phylogeny and disease 
Natasa Przulj. 
Presenter affiliation: Imperial College London, London, United 
Kingdom. 
 
 
 
13 
  
A protein interaction wiring of the human spliceosome 
Anna Hegele, Atanas Kamburov, Crysovalantis Sourlis, Arndt 
Grossmann, Sylvia Wowro, Mareike Weimann, Vlad Pena, Reinhard 
Lührmann, Ulrich Stelzl. 
Presenter affiliation: Max Planck Institute for Molecular Genetics (MPI-
MG), Berlin, Germany. 
 
 
 
 
 
14 
  
Protein complexes and networks for green biotech 
Jelle Van Leene, Dominique Eeckhout, Geert Persiau, Eveline Van De 
Slijke, Erwin Witters, Geert De Jaeger. 
Presenter affiliation: VIB-Ghent University, Gent, Belgium. 
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THURSDAY, August 12—2:00 PM 
 
 
SESSION 3 GENETIC NETWORKS 
 
Chairperson: H. Zhu, Johns Hopkins University, Baltimore, Maryland, USA 
 
 
Analyzing regulatory circuitry with expression-profile phenotypes 
Frank Holstege. 
Presenter affiliation: University Medical Centre Utrecht, the 
Netherlands. 
 
 
 
16 
  
Epistasis in context—Understanding genetic interactions through 
an exhaustive modular decomposition 
Jeremy Bellay, Gowtham Atluri, Gaurav Pandey, Charles Boone, Vipin 
Kumar, Chad Myers. 
Presenter affiliation: University of Minnesota, Minneapolis, Minnesota. 
 
 
 
 
17 
  
Functional gene network of a pathogenic bacterium, 
Pseudomonas aeruginosa 
Sun-Gou Ji, Insuk Lee. 
Presenter affiliation: Yonsei University, Seoul, South Korea. 
 
 
 
18 
  
Why would a mutation kill me, but not you? 
Ben Lehner. 
Presenter affiliation: EMBL-CRG Systems Biology Unit and ICREA, 
Barcelona, Spain. 
 
 
 
19 
  
Sox9-directed gene regulatory network controlling murine 
embryonic skeletal development 
Sook Peng Yap, Thomas Lufkin. 
Presenter affiliation: Genome Institute of Singapore, Singapore. 
 
 
 
20 
  
Functional vs. topological predictions of essential genes of the 
food-borne pathogen Campylobacter jejuni 
Aline Metris, Mark Reuter, Duncan J. Gaskin, Arnoud H. van Vliet, 
Jozsef Baranyi. 
Presenter affiliation: Institute of Food Research, Norwich, United 
Kingdom. 
 
 
 
 
 
21 
  
Protein networks reveal detection bias and species consistency 
when viewed through information-theoretic glasses. 
Franca Fraternali, Luis P. Fernandes, Jens Kleinjung, Alessia 
Annibale, Anthonius A. Coolen. 
Presenter affiliation: King’s College London, London, United Kingdom. 
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 xi 
THURSDAY, August 12—5:00 PM 
 
 
POSTER SESSION I 
 
  
Reducing redundancy in biological networks 
Mochamad Apri, Jaap Molenaar, Simon van Mourik, Maarten de Gee. 
Presenter affiliation: Wageningen University, Wageningen, 
Netherlands; Netherlands Consortium for Systems Biology, 
Amsterdam, Netherlands. 
 
 
 
 
23 
  
Form, function and evolution of specialized cilia transport 
machinery—Comparing the fold architectures and interactions of 
BBSome and IFT protein complexes 
J. Fernando Bazan, Maxence V. Nachury. 
Presenter affiliation: Genentech, South San Francisco, California. 
 
 
 
 
24 
  
Metabolic network dynamics during seed development in 
Arabidopsis 
Raju Datla, Xiang Daoquan, Prakash Venglat, Chabane Tibiche, 
Gopalan Selvaraj, Mathieu Cloutier, Edwin Wang. 
Presenter affiliation: National Research Council of Canada, Saskatoon, 
Canada. 
 
 
 
 
 
25 
  
SLiMFinder—A web server to find novel, significantly over-
represented, short protein motifs 
Norman E. Davey, Niall J. Haslam, Denis C. Shields, Richard J. 
Edwards. 
Presenter affiliation: University of Southampton, Southampton, United 
Kingdom. 
 
 
 
 
 
26 
  
Functional analysis of tissue-specific protein interactions based 
on RNA-sequencing data 
Dorothea Emig, Mario Albrecht. 
Presenter affiliation: Max Planck Institute for Informatics, Saarbrücken, 
Germany. 
 
 
 
 
27 
  
Inferring gene regulatory networks from expression data—
Principles and analysis 
Frank Emmert-Streib, Gokmen Altay. 
Presenter affiliation: Queen's University Belfast, Belfast, United 
Kingdom. 
 
 
 
 
28 
  
 xii 
A network-based approach for establishing connections between 
diseases and drugs 
Hai Fang, Owen Rackham, Julian Gough. 
Presenter affiliation: University of Bristol, United Kingdom. 
 
 
 
29 
  
Pathways to cognitive deficits in Down syndrome 
Katheleen J. Gardiner, Krzysztof J. Cios. 
Presenter affiliation: University of Colorado Denver, Aurora, Colorado. 
 
 
30 
  
System-level control properties of the eukaryotic mRNA 
translation pathway 
Shichina Kannambath, Helena Firczuk, Jürgen Pahle, Hans 
Westerhoff, Pedro Mendes, John McCarthy. 
Presenter affiliation: University of Manchester, Manchester, United 
Kingdom. 
 
 
 
 
 
31 
  
Implementing phylogenetic statistical analysis to establish gene 
regulatory networks in baculoviruses 
Hagit Katzov-Eckert, Juliana Velasco-Oliveira, Luis Diambra, Paolo 
Zanotto. 
Presenter affiliation: University of São Paulo, São Paulo, Brazil. 
 
 
 
 
32 
  
High-throughput screening for virus-host interactions 
Manfred Kögl, Frank Schwarz, Haas Jürgen, Korn Bernhard. 
Presenter affiliation: German Cancer Research Center, Heidelberg, 
Germany. 
 
 
 
33 
  
Genetic networks that underly quantitative and qualitative 
aspects of the RNA transcription in BXH/HXB rats 
Marieke Simonis, Vyacheslav Koval, Victor Guryev, Edwin Cuppen. 
Presenter affiliation: Hubrecht Institute, Universitair Medisch Centrum 
Utrecht, Utrecht, Netherlands. 
 
 
 
 
34 
  
Combined use of metabolomics, lipidomics, fluxomics and 
bioenergenics to determine earliest effects of PPARγ stimulation 
on 3T3-L1 differentiation 
Gustavo Palacios, Bhavapriya Vaitheesvaran, Haitao Lu, Irwin Kurland. 
Presenter affiliation: Albert Eistein College of Medicine, Bronx, New 
York. 
 
 
 
 
 
35 
  
Transcriptional analysis of salt tolerance genes in Tunisian 
grapevines 
Ahmed Mliki, Samia Daldoul, Michael Hoefer. 
Presenter affiliation: Centre de Biotechnologie de Borj-Cedria, Hamma-
lif, Tunisia. 
 
 
 
 
36 
  
 xiii 
Prioritizing candidate genes by network analysis of differential 
expression using machine learning approaches 
Daniela Nitsch, Yves Moreau. 
Presenter affiliation: K.U. Leuven, Leuven, Belgium. 
 
 
 
37 
  
Strolling inside the comprehensive HIV-1 host cell interactome 
Marcela Nunez, Petra Tafelmeyer, Jean-Christophe Rain, Fanny 
Moisant, Philippe Leclerc, Vincent Collura, Richard Benarous, Etienne 
Formstecher. 
Presenter affiliation: Hybrigenics, Paris, France. 
 
 
 
 
38 
  
Pathway reconstruction with cell-type-specific co-expression 
profiles in Arabidopsis root 
Taeyun Oh, Insuk Lee. 
Presenter affiliation: Yonsei University, Seoul, South Korea. 
 
 
 
39 
  
Analysis and prediction of protein-mRNA interactions in yeast 
Vera Pancaldi, Jürg Bähler. 
Presenter affiliation: University College London, London, United 
Kingdom. 
 
 
 
40 
  
A reproducible systematic approach for the mapping of human 
kinases interactome 
Roberto Sacco, Keiryn Bennett, Jacques Colinge, Giulio Superti-Furga. 
Presenter affiliation: CeMM, Vienna, Austria. 
 
 
 
41 
  
Combinatorial depletion analysis to assemble the network 
architecture of the SAGA and ADA chromatin remodeling 
complexes 
Mihaela E. Sardiu, Kenneth Lee, Laurence Florens, Jerry Workman, 
Michael P. Washburn. 
Presenter affiliation: Stowers Institute for Medical Research, Kansas 
City, Missouri. 
 
 
 
 
 
 
42 
  
Elucidating compounds’ mode of action by means of weighted 
protein interactions 
Ramona Schmid*, Patrick Baum*, Carina Ittrich, Katrin Fundel-
Clemens, Bärbel Lämmle, Fabian Birzele, Andreas Weith, Benedikt 
Brors, Roland Eils, Detlev Mennerich, Karsten Quast. 
Presenter affiliation: Boehringer Ingelheim Pharma GmbH & Co. KG, 
Biberach/Riss, Germany. 
 
 
 
 
 
 
43 
 
 
 
 xiv 
Cell-type-specific networks—A mining method and their relations 
to disorders and evolution 
Jun Sese. 
Presenter affiliation: Ochanomizu University, Tokyo, Japan. 
 
 
 
44 
  
Gene network comparison based on multiple time-course 
microarray data 
Teppei Shimamura, Seiya Imoto, Rui Yamaguchi, Masao Nagasaki, 
Satoru Miyano. 
Presenter affiliation: University of Tokyo, Tokyo, Japan. 
 
 
 
 
45 
  
Construction of a model of mitochondrial metabolism and its use 
in investigating disease 
Anthony C. Smith, Alan J. Robinson. 
Presenter affiliation: MRC Mitochondrial Biology Unit, Cambridge, 
United Kingdom. 
 
 
 
 
46 
  
Network modeling suggests new mechanistic details underlying 
Alzheimer’s disease 
Montserrat Soler-Lopez, Andreas Zanzoni, Ricart Lluis, Ulrich Stelzl, 
Patrick Aloy. 
Presenter affiliation: Institute for Research in Biomedicine, Barcelona, 
Spain. 
 
 
 
 
 
47 
  
Bistable RLR-IFNβ signaling system determines apoptotic cell 
fate 
Sun-Young Hwang, Kye-Yeon Hur, Seung-Hwan. Kim, Jeong-Rae Kim, 
Kwang-Hyun Cho, Joo-Yeon Yoo. 
Presenter affiliation: POSTECH, Pohang, South Korea. 
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FRIDAY, August 13—9:00 AM 
 
 
SESSION 4 NETWORK MEDICINE 
 
Chairperson: P. Braun, Dana-Farber Cancer Institute, Boston,  
  Massachusetts, USA 
 
 
A network medicine approach to human disease 
Patrick Aloy. 
Presenter affiliation: Institute for Research in Biomedicine, Barcelona, 
Spain. 
 
 
 
49 
  
 xv 
Nuclear receptors, transcriptional networks and cancer 
Kevin White. 
Presenter affiliation: University of Chicago, Illinois. 
 
 
50 
  
Network-based classifiers for identifying driver-mutation-bearing 
cancer genes 
Ara Cho, JungEun Shim, Insuk Lee. 
Presenter affiliation: Yonsei University, Seoul, South Korea. 
 
 
 
51 
  
Integrative systems biology analysis and visualization of relevant 
subnetwork modules and pathways in phenotypic traits and 
diseases 
Tanja Kunej, Peter Dovc, Jernej Ogorevc, Eva Ceh, Minja Zorc, Irena 
Godnic, Dasa Jevsinek Skok, George A. Calin, Jana Ferdin, Crt 
Gorup, Carlo V. Cannistraci. 
Presenter affiliation: University of Ljubljana, Domzale, Slovenia. 
 
 
 
 
 
 
52 
  
Molecular networks in leukemia and innate immunity 
Giulio Superti-Furga, Florian Grebien, Jacques Colinge, Oliver 
Hantschel, Tilmann Bürckstümmer, Roberto Sacco, Evren Karayel, 
Adriana Goncalves, Christoph Baumann, Andreas Pichlmair, Alexei 
Stukalov, Andre Müller, Keiryn L. Bennett. 
Presenter affiliation: CeMM, Vienna, Austria. 
 
 
 
 
 
53 
  
Molecular mechanisms in schizophrenia uncovered with systems 
genetics 
Jacob J. Michaelson, Andreas Beyer. 
Presenter affiliation: Biotechnology Center, TU Dresden, Dresden, 
Germany. 
 
 
 
 
54 
  
Proteomics and systems analysis of estrogen-induced cell 
growth or cell death in breast cancer cells 
Zhang-Zhi Hu, Benjamin L. Kagan, Lihua Zhang, V. Craig Jordan, 
Anna T. Riegel, Anton Wellstein. 
Presenter affiliation: Georgetown University, Washington, DC. 
 
 
 
 
55 
  
Rewiring of inflammation and tumor susceptibility networks in 
skin cancer 
David A. Quigley, Minh D. To, Il-Jin Kim, Donna G. Albertson, Jonas 
Sjolund, Allan Balmain. 
Presenter affiliation: University of California San Francisco, San 
Francisco, California. 
 
 
 
 
 
56 
 
 
 xvi 
FRIDAY, August 13—2:00 PM 
 
 
SESSION 5 GENE REGULATORY NETWORKS II 
 
Chairperson: G. Superti-Furga, Austrian Academy of Sciences, Vienna, 
Austria 
 
Gene regulatory networks in systems physiology 
A.J. Marian Walhout. 
Presenter affiliation: University of Massachusetts Medical School, 
Worcester. 
 
 
 
57 
  
Trey Ideker. 
Presenter affiliation: University of California, San Diego. 
 
  
Robust patterning in Arabidopsis flowers—MADS science 
Simon van Mourik, Richard Immink, Susan Urbanus, Jaap Molenaar. 
Presenter affiliation: Plant Research International, Wageningen, 
Netherlands. 
 
 
 
58 
  
Heng Zhu. 
Presenter affiliation: Johns Hopkins University, Baltimore, Maryland. 
 
  
A taxonomy of networks 
JP Onnela, D Fenn, S Reid, P Mucha, M Porter, N Jones. 
Presenter affiliation: University of Oxford, Oxford, United Kingdom. 
 
 
59 
  
Protein interaction networks—The edge of regulation 
Guilhem Chalancon, M. Madan Babu. 
Presenter affiliation: MRC Laboratory of Molecular Biology, Cambridge, 
United Kingdom; Ecole Normale Superieure de Cachan, Cachan, 
France. 
 
 
 
 
60 
  
Singleton and duplicated hubs in the evolution of protein 
interaction networks 
Matteo D’Antonio, Francesca D. Ciccarelli. 
Presenter affiliation: European Institute of Oncology (IEO), Milan, Italy. 
 
 
 
61 
 
 
FRIDAY, August 13—5:10 PM 
 
 
POSTER SESSION II 
 
See Poster Session I for list of posters. 
 xvii 
SATURDAY, August 14—9:00 AM 
 
 
SESSION 6 SIGNALLING NETWORKS 
 
Chairperson: A. Godzik, Burnham Institute for Medical Research, La  
  Jolla, California, USA 
 
  
Immune signaling landscape—Interrogating single cells in 30 
dimensions 
Rachel Melamed, Elad David-Amir, Sean C. Bendall, Erin Simonds, 
Karen Sachs, Garry Nolan, Dana Pe’er. 
Presenter affiliation: Columbia University, New York, New York. 
 
 
 
 
62 
  
Widespread induction of genetic networks in response to DNA 
damage 
Sourav Bandyopadhyay, Monika Mehta, Ruedi Aebersold, Michael-
Christopher Keogh, Nevan J. Krogan, Trey Ideker. 
Presenter affiliation: University of California-San Diego, La Jolla, 
California. 
 
 
 
 
 
63 
  
Peptide-mediated interactions in high-resolution 3D structures 
Amelie Stein, Patrick Aloy. 
Presenter affiliation: Institute for Research in Biomedicine (IRB) 
Barcelona, Barcelona, Spain; Barcelona Supercomputing Center 
(BSC), Barcelona, Spain. 
 
 
 
 
64 
  
Comparative logical models of signaling networks in normal and 
transformed hepatocytes 
Julio Saez Rodriguez, Leonidas Alexopoulos, Melody K. Morris, Dan 
Kirouac, Jonathan Epperlein, Regina Samaga, Steffen Klamt, Douglas 
A. Lauffenburger, Peter K. Sorger. 
Presenter affiliation: Harvard Medical School, Boston, Massachusetts; 
MIT, Cambridge, Massachusetts. 
 
 
 
 
 
 
65 
  
A systems biology approach to limb bud development: tools and 
modules 
Rolf Zeller. 
Presenter affiliation: University of Basel, Basel, Switzerland. 
 
 
 
66 
  
System wide analysis of the human ubiquitin E3-RING interaction 
network 
Jonathan D. Woodsmith, Chris M. Sanderson. 
Presenter affiliation: University of Liverpool, Liverpool, United 
Kingdom. 
 
 
 
 
67 
 xviii 
Functional genomics strategies to unravel phosphorylation 
networks that control the DNA damage stress response in ES 
cells 
J. Carreras Puigvert, L. von Stechow, R. Siddappa, A. Pines, L. H.F. 
Mullenders, B. van de Water, E. H.J. Danen. 
Presenter affiliation: Leiden University, LACDR, Leiden, Netherlands. 
 
 
 
 
 
68 
  
Evolution of phosphoregulation—From interactions to function 
Pedro Beltrao, Jonathan C. Trinidad, Wendell A. Lim, Alma L. 
Burlingame, Nevan J. Krogan. 
Presenter affiliation: University of California-San Francisco, San 
Francisco, California. 
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SATURDAY, August 14—2:00 PM 
 
 
SESSION 7 METABOLIC NETWORKS 
 
Chairperson: D. Pe'er, Columbia University, New York, New York, USA 
 
  
Function dictates topology in biochemical networks 
Chao Tang. 
Presenter affiliation: University of California San Francisco, San 
Francisco, California. 
 
 
 
70 
  
Extending the structural reconstruction of the metabolic network 
of T. maritma 
Ying Zhang, Andrei Osterman, Adam Godzik. 
Presenter affiliation: Sanford-Burnham Medical Research Institute, La 
Jolla, California. 
 
 
 
 
71 
  
Information processing by biochemical networks—A dynamic 
approach 
Clive Bowsher. 
Presenter affiliation: University of Cambridge, Cambridge, United 
Kingdom. 
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 xix 
SATURDAY, August 14—3:45 PM 
 
 
KEYNOTE SPEAKER 
 
  
Deaf plants, bleeding yeast, and other surprising disease models 
from deeply conserved gene networks 
Edward M. Marcotte, Kriston L. McGary, Tae Joo Park, Hye Ji Cha, 
John O. Woods, Martin Blom, John B. Wallingford. 
Presenter affiliation: University of Texas, Austin, Texas. 
 
 
 
 
73 
  
 
 
SATURDAY, August 14 
 
 
CONFERENCE BANQUET 
 
 
5:00 PM  Drinks  7:00 PM  Dinner 
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PROTEIN-PROTEIN INTERACTION NETWORK OF POST-
TRANSCRIPTIONAL GENE EXPRESSION REGULATION IN 
TRYPANOSOMA CRUZI  
 
Christian M Probst1,2, Henrique Preti1, Daniela P Pavoni1, Fabricio K 
Marchini1,2, Newton M Vidal2, Marco A Krieger1  
 
1Carlos Chagas Institute - ICC/FIOCRUZ, Functional Genomics 
Laboratory, Curitiba, 81350-010, Brazil, 2Carlos Chagas Institute - 
ICC/FIOCRUZ, Bioinformatics Laboratory, Curitiba, 81350-010, Brazil 
 
Trypanosoma cruzi is a protozoan parasite, affecting more than 15 million 
people in South and Central Americas and having inefficient treatment. 
Besides being a public health problem, it has peculiar characteristics that 
make it an interesting study object for basic biology; also, it is an ancient 
eukaryote, and its study can provide clues to cellular processes distinct from 
those of other model organisms. One of its major features is the regulation 
of gene expression, which occurs post-transcriptionally, and studying the 
processing, storage and degradation of mRNA is extremely important for 
understanding the gene expression control mechanisms of this organism. 
RNA-binding proteins are extremely important in regulating these 
processes, as through their interaction with specific mRNAs they can define 
mRNA fate. We are conducting several large scale analyses of T. cruzi 
molecular biology, including RNA-seq and mass spectrometry, which are 
providing important clues about T. cruzi biology. Their integration is 
expected to improve our knowledge, but this is not trivial; a possible way to 
improve the initial integration is to build a map of protein-protein 
interaction (PPI). Aiming to create an initial map of RNA-binding PPI, we 
have constructed a T. cruzi ORFeome, comprising ~8,000 proteins. We 
have selected ~400 proteins, consisting of all putative RNA-binding or 
those that are part of potential interacting functional complexes, as 
ribosome, splicing and decay machinery, among others and have screened 
them by a yeast two-hybrid (Y2H) array approach. Using two stringency 
criteria, we have identified 82 and 34 interactions, of 73 and 29 proteins, 
respectively. Some of these interactions were also identified in other 
interactome datasets, but only for a small fraction. Although this raises 
some concerns about false positives, we hypothesize that, due to its large 
evolutionary distance from other model organisms whose interactome is 
well studied, and to the specificity of its post-transcriptional gene 
expression regulation, comparison of interactome datasets based on 
orthologs is of low power to detect true interactions. We are currently 
performing in vivo analysis of selected interactions to assess the specificity 
of our results. Besides that, we are integrating the several large scale data 
we have generated in our group over the interaction network, as well as 
increasing the coverage of the whole T. cruzi interactome. 
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HIGH-RESOLUTION TRANSCRIPTOME-WIDE IDENTIFICATION OF 
HUR REGULATORY ELEMENTS 
 
Neelanjan Mukherjee1, Jeff Nusbaum2, David Corcoran3, Uwe Ohler3, 
Thomas Tuschl2, Jack Keene1  
 
1Duke University Medical Center, Molecular Genetics and Microbiology, 
Durham, NC, 27110, 2Rockefeller University, Laboratory of RNA 
Molecular Biology, New York, NY, 10065, 3Duke University Institue for 
Genome Science and Policy, Biostatistics & Bioinformatics, Durham, NC, 
27710 
 
RNA-binding proteins (RBPs) and noncoding RNAs are posttranscriptional 
regulatory factors that control the fate of each mRNA species. RBPs 
coordinate all aspects of RNA processing including splicing, export, 
localization, stability, and translation. HuR, a member of the ELAV/Hu 
family of RBPs, has been shown to positively regulate the stability and 
translation of target mRNAs through AU-rich elements (AREs) typically 
found in the 3’ untranslated region (UTR) of mRNAs encoding many 
immediate early genes, inflammatory cytokines, and growth factors. While 
many studies have identified mRNAs associated with HuR, the precise 
binding sites have not been identified on a genome-wide scale. 
Furthermore, the extent to which HuR regulates mRNA processing events, 
such as splicing and poly-adenylation, has not been examined globally.  
We identified precise HuR-RNA interaction sites transcriptome-wide at a 
high resolution utilizing a recently developed technology, PAR-CLIP 
(Photoactivatable-Ribonucleoside-Enhanced Crosslinking and 
Immunoprecipitation). As expected there were many binding sites in the 3’ 
UTR of mRNAs. Surprisingly, there were a substantial number of intronic 
binding sites, suggesting HuR is involved in pre-mRNA processing.  
Utilizing Affymetrix exon arrays, we identified mRNAs that require HuR 
for maintaining their expression levels and RNA processing. Integration of 
binding data with knockdown expression data reveals that HuR positively 
regulates the expression of target mRNAs. Furthermore, the degree of 
binding was proportional to extent of HuR-dependent regulation of gene 
expression. Unexpectedly, the positive regulation remained true for mRNAs 
that only contained intronic HuR binding sites. 
Integration of the data revealed known functions of HuR, for example HuR 
positively regulates the expression of functionally related proteins involved 
in the regulation of cell cycle. We also discovered novel potential cellular 
functions of HuR. Our data suggest that HuR directly regulates the 
expression of mRNAs encoding amino-acyl tRNA-synthetases (ARSs). The 
majority of the twenty ARSs are positively regulated by HuR and contain 
HuR binding sites. Nine ARSs form a macromolecular complex which 
include 3 other non-ARS proteins. The mRNAs encoding these three 
proteins are also directly bound and regulated by HuR. The tRNA multi-
synthetase macromolecular complex, a highly multifunctional complex 
important in many diseases, may represent a post-transcriptional RNA 
operon coordinated by HuR. 
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INDIVIDUAL VARIATION IN GENE EXPRESSION IN GENETIC AND 
NETWORK STUDIES 
 
Renuka R Nayak1, Vivian G Cheung2  
 
1Medical Scientist Training Program, University of Pennsylvania, 
Philadelphia, PA, 19072, 2HHMI/ U Pennsylvania, Pediatrics & Genetics, 
Philadelphia, PA, 19072 
 
We use the extensive variation in expression levels of human genes to study 
gene functions and regulations. We measured gene expression of human B-
cells from hundreds of unrelated and related individuals. Using these data, 
we carried out genetics of gene expression (GOGE) studies and constructed 
gene coexpression networks.  
 
In GOGE studies, we treated expression levels of genes (“expression 
phenotypes”) as quantitative traits and identified regulatory variants that 
influence individual differences in gene expression. We found that about 
10% of these regulatory variants act in cis to influence gene expression, the 
remaining ones act in trans. We validated these findings molecularly by 
gene knockdown and metabolic assays. The results include over 1,000 
polymorphic regulator-target gene pairs.  
 
In parallel, we use gene expression data of >8 million gene pairs to 
construct coexpression network. The resulting networks consist mainly of 
large connected components and have scale-free topologies. We found that 
neighboring genes often share similar functions; thus, the networks allowed 
us to identify biological processes and characterize functions of genes.  
 
In this presentation, I will describe the results of using variation in human 
gene expression in genetic and network studies to identify gene functions 
and regulatory relationships. I will also discuss implications of these 
findings for human diseases. 
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INVESTIGATING THE CONNECTION BETWEEN THE NUCLEAR 
ORGANIZATION AND THE PRIMARY STRUCTURE IN SENESCENT 
CHROMATIN 
 
Tamir Chandra1, Jean-Yves Thuret2, Lixiang Xue1, Rekin's Janky3, Shamith 
A Samarajiwa1, Scott Newman4, Masako Narita1, Agustin Chicas5, Paul A 
Edwards4, Madan M Babu3, Scott W Lowe5, Simon Tavare1, Masashi 
Narita1  
 
1CRUK , Cambridge Research Institute, Cambridge, CB20RE, United 
Kingdom, 2CEA , iBiTec-S, Paris, 91191, France, 3Medical Research 
Council - Laboratory of Molecular Biology, Structural Studies Division, 
Cambridge, CB20QH, United Kingdom, 4 Cambridge University, 
Department of Pathology and Hutchison/MRC Research Centre, 
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We have previously identified a global and progressive heterochromatic 
structure within senescent human diploid fibroblasts – senescence 
associated heterochromatic foci (SAHFs) – which have since been widely 
used as a marker of senescence. Our current model is that SAHFs contribute 
to the altered gene expression profile seen in senescent cells. However, the 
structural detail of SAHFs is still unclear. Here we take cell-biological and 
genomic approaches to analyze in great detail how histone marks are 
reorganized during SAHF formation. We find that SAHFs are distinct 
multi-layer structures, in which H3K9me3 is enriched in the ‘core’ of 
SAHFs, surrounded by an H3K27me3 layer, which separates the core from 
the transcriptionally active H3K4/36me3 region. Consistent with our model, 
chromatin IP coupled with deep sequencing (ChIP-seq) for histone marks in 
these three layers reveals that these marks are dynamically redistributed at 
subsets of genic regions, including cyclin A and p16INK4A. Strikingly, 
however, the data also show that the global ‘landscapes’ of the silencing 
marks (H3K9me3 and H3K27me3) are largely unchanged, despite such a 
drastic alteration in chromatin structure. This indicates that the non-genic 
‘stable’ H3K9me3 mark nucleates SAHFs, and that the global re-
distribution or accumulation of H3K9/27me3 is not necessary for SAHF 
formation. Thus our combined approach of cell biology and biochemistry 
provides insight into the relationship between the higher-order and primary 
structures of silencing histone marks. 
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TRANSCRIPTION NETWORKS IN THE DNA DAMAGE STRESS 
RESPONSE IN ES CELLS* 
 
R Siddappa, L von Stechow, J Carreras Puigvert, B van de Water, E H.J. 
Danen  
 
Leiden University/LACDR, Division of Toxicology, Leiden, 2300RA, 
Netherlands 
 
Cells experience constant genomic insult by exogenous and endogenous 
DNA damaging agents. If the damage is unrepaired or escapes the 
surveillance machinery, this can lead to ageing, degenerative diseases and 
cancer. DNA damage is sensed by ATM/ATR protein kinases and activates 
downstream checkpoint kinases and a p53 signaling cascade to control 
repair, cell cycle and survival. In this project, we make use of a gene 
family-wide short interference (si)RNA transcription factor library to 
identify transcription factors that are involved in the apoptotic response to 
various DNA-damaging drugs in ES cells. Primary high-throughput 
screening for cell viability has revealed potential regulators of the 
sensitivity of ES cells to the DNA damaging drug cisplatin. The hits are 
validated in a secondary deconvolution screen for cell survival and further 
evaluated in a real time apotosis assay using automated imaging. From 
~1600 transcription factors tested in the primary screen, 140 have been 
identified as potential hits, and have entered the validation process. In 
parallel, transcriptomics data have been obtained from similar treatments of 
ES cells exposed to Cisplatin. Bioinformatics analysis of these two datasets 
is used to link identified transcription factors to transcriptional regulation of 
their target genes. We aim to construct a global transcriptional network 
model for DNA damage signaling in ES cells. This will be further tested for 
multiple compounds and cell types, including cancer cells. This will allow 
us to define potential biomarkers and new druggable targets in order to 
improve chemotherapeutic treatments.  
*Supported by the Netherlands Toxicogenomics Center.  
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IMEX – WHEN THE MAJOR MOLECULAR INTERACTION 
DATABASES COLLABORATE TOGETHER TO SERVE YOU 
BETTER. 
 
Samuel Kerrien, The IMEx Consortium, Henning Hermjakob  
 
European Bioinformatics Institute, Proteomics Services Team, Hinxton, 
CB101SD, United Kingdom 
 
Molecular interaction data is now collected by an increasing number of 
databases, leaving the user with a bewildering choice of where to look for 
information on their protein of interest. Several resources exist which merge the 
content of a number of databases, but the management of redundant data is 
often challenging. The International Molecular Exchange consortium (IMEx 
[1]) is a group of major public interaction data providers sharing curation effort 
who have agreed to 
· Develop and work to a single set of curation rules when capturing data from 
both directly deposited interaction data or from publications in peer-reviewed 
journals 
· Capture full details of an interaction in a “deep” curation model 
· Perform a complete curation of all protein-protein interactions experimentally 
demonstrated within a publication 
· Make these interaction available in a single search interface on a common 
website 
· Provide the data in standards compliant download formats 
· Release a significant number of IMEx records every year 
· Make all IMEx records freely accessible under the Creative Commons 
Attribution License 
 
Current IMEx members are IntAct, MINT, DIP, MPact, MatrixDB, MPIDB, 
BioGRID and Molecular Connections. From production start in February 2010 
to May 2010, the IMEx consortium has released 50,359 interactions as IMEx 
records. The dataset will automatically increase with every release by a 
participating, member database. Data is made available in standards-compliant 
tab-delimited and XML formats, enabling users to visualize the data in a wide 
range of tools such as Cytoscape and the R Bioconductor software. IMEx data 
and documentation is available from [1]. IMEx data access is based on 
PSICQUIC, the PSI Common QUery InterfaCe. PSICQUIC is an effort from 
the HUPO Proteomics Standard Initiative (HUPO-PSI) to standardise the access 
to molecular interaction databases programmatically. PSICQUIC is a client-
server technology that allows users to effortlessly access the IMEx data and 
over 2,000,000 binary interactions that have been shared across 12 data 
providers so far. The PSICQUIC Registry [2] is available to expose the list of 
services currently available. The PSICQUIC view [3] is a client that enables 
users to query all PSICQUIC registered service from a single web site. 
 
[1] http://imex.sourceforge.net/ 
[2] 
http://www.ebi.ac.uk/Tools/webservices/psicquic/registry/registry?action=STATUS 
[3] http://www.ebi.ac.uk/Tools/webservices/psicquic/view/ 
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THE GENETIC LANDSCAPE OF A CELL 
 
Charles Boone  
 
University of Toronto, Banting and Best Department of Medical Research, 
Toronto, M4T 1K9, Canada 
 
A genome-scale genetic interaction map was constructed by examining 5.4 
million gene-gene pairs for synthetic genetic interactions, generating 
quantitative genetic interaction profiles for ~75% of all genes in the 
budding yeast, Saccharomyces cerevisiae. A network based on genetic 
interaction profiles reveals a functional map of the cell in which genes of 
similar biological processes cluster together in coherent subsets and highly 
correlated profiles delineate specific pathways to define gene function. The 
global network identifies functional cross-connections between all 
bioprocesses, mapping a cellular wiring diagram of pleiotropy. Genetic 
interaction degree correlated with a number of different gene attributes, 
which may be informative about genetic network hubs in other organisms. 
Extensive and unbiased mapping of the genetic landscape also provides a 
key for interpretation of chemical-genetic interactions and drug target 
identification. 
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BIOCHEMICAL APPROACHES TO BIOMOLECULAR NETWORKS 
 
Anne-Claude Gavin  
 
EMBL, Heidelberg, D-69117, Germany 
 
Since the sequencing of the first eukaryotic genome, Saccharomyces 
cerevisiae, more than 10 years ago, explosion of new analytical tools in the 
fields of transcriptomics, proteomics and metabolomics contributes ever-
growing molecular repertoires of the building blocks that make up a cell. 
Biology does not rely on biomolecules acting in isolation. Biological 
function depends on the concerted action of molecules acting in protein 
complexes, pathways or networks. Biomolecular interactions are central to 
all biological functions. In human, for example, impaired or deregulated 
protein–protein or protein–metabolite interaction often leads to disease. 
Recent strategies have been designed that allow the study of interactions 
more globally at the level of entire biological systems. We will discuss the 
use of these biochemical approaches to genome-wide screen in model 
organisms. 
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A DYNAMIC VIEW OF DOMAIN-MOTIF INTERACTION 
NETWORKS 
 
Hanah Margalit, Eyal Akiva  
 
The Hebrew University of Jerusalem, Microbiology and Molecular 
Genetics, Jerusalem, 91120, Israel 
 
Cellular protein interaction networks involve many transient interactions 
that are mediated by domains that bind short linear motifs. These domain-
motif pairs define functional units that are often involved in key cellular 
processes and need to be tightly regulated. A common strategy of the cell to 
control protein function and interaction is by post-translational 
modifications of specific residues, especially phosphorylation. Indeed, there 
are examples where domain-motif interactions are enhanced or prevented 
by phosphorylation of the motif's residues. Here we carry out a large-scale 
integrative analysis to examine the extent of this mechanism in the cellular 
networks. By integrating large-scale experimental data of domain-motif 
interactions and of phosphorylation events we demonstrate an intriguing 
coupling between the two, where residue phosphorylation in or near the 
motifs is implied to be associated with prevention or enabling of the 
domain-motif interaction. We study the evolutionary traces of the coupling 
between domain-motif interaction and phopshorylation and its functional 
implications. Our results suggest that phosphorylation plays a role as a 
specificity switch between proteins that bind to the same protein regions 
either through the same domain or through different domains. Our findings 
suggest that in many cases the interaction between domains and linear 
motifs depends on the phopsphorylation state of the motifs, adding a 
dynamic aspect to domain-motif interaction and defining interaction-
regulation modules. 
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NETALIGNER – FAST AND ACCURATE ALIGNMENT OF PROTEIN 
INTERACTION NETWORKS. 
 
Roland A Pache1,2, Patrick Aloy1,2,3  
 
1Institute for Research in Biomedicine (IRB) Barcelona, Structural and 
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Recent advances in genome sequencing and large-scale interaction detection 
provided comprehensive lists of the macromolecules present in an organism 
and how they interact to create complex biological systems. To understand 
and interpret this huge amount of data, we need novel bioinformatics 
approaches. Based on the success of sequence alignment in unveiling 
genome function, organization and evolution, alignment of protein 
interaction networks is expected to vastly increase our understanding of 
biological processes, their evolution and adaptation to changing 
environmental conditions. However, existing network alignment programs 
still suffer from certain limitations that prevent them from being widely 
applied.  
Here, we present a novel network alignment algorithm, NetAligner, that 
addresses those limitations, featuring both fast alignment of query pathways 
or protein complexes to whole species interactomes and fast interactome to 
interactome alignment for finding conserved complexes or subnetworks 
between two organisms. NetAligner is able to align networks of arbitrary 
topology and to accurately model evolutionary duplication events through 
many-to-many homology relationships. In addition to considering 
interaction reliabilities to address potential false positives, NetAligner is the 
first network alignment algorithm that offers the option to predict conserved 
interactions to counter the high amount of false negatives in current 
interactomes, considerably increasing alignment performance in some 
cases.  
We conducted several independent benchmarks, in which NetAligner 
consistently outperformed the current standard in the field, while requiring 
only a fraction of the runtime. This, together with its fast assessment of the 
statistical significance of alignment solutions, makes NetAligner ideal for 
large-scale application in comparative interactomics experiments.  
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TRANSIENT COMPLEXES ALONG PROTEIN-PROTEIN 
ASSOCIATION 
 
Michal Harel, Gideon Schreiber  
 
Weizmann Institute of Science, Biological Chemistry, Rehovot, 76100, 
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How do proteins associate quickly and specifically is a question of ongoing 
interest in the emerging fields of systems biology, rational protein design, 
medicine and more, as these reactions are involved in most biological 
processes. Proteins interact with variable affinities from mM to sub-pM and 
at rates of association and dissociation spanning over six orders of 
magnitude, yet their degree of specificity is not directly related to either 
their affinity or rate of binding. Many proteins can interact with multiple 
partners either simultaneously or separately, and this is one of the reasons 
for their ability to form complex networks. These observations are merely 
part of the great interest in this field of study. 
 
The process of protein-protein association begins with their random 
collision, which may further develop into an encounter complex, followed 
by a transition state, and finally complex formation can occur. We 
combined experimental and computational tools in order to characterize the 
nature of both the transition state and the encounter complex for protein-
protein association. The transition state was analyzed by double mutant 
cycles and computational modeling, while the encounter complex was 
examined by a combination of Brownian dynamics simulations and 
experimental examination. Two types of transition states were found: 
specific and diffusive, which were interchangeable by rational design. 
While the specific transition state can be structurally modeled, the diffusive 
transition state lacks preferred structures, which may result in a slower 
association. The encounter complex analysis indicated that encounters 
faraway from the interface are futile, while encounters at the vicinity of the 
interface are fruitful and contribute to the association reaction. Furthermore, 
the free energy landscape of the encounter complex can be drastically 
changed upon mutation. The comparison between the encounter complex 
and the transition state suggests an energetic funnel, in which the encounter 
complex is in the broader side of it, while the transition state is in the more 
narrow side, towards the final complex at the bottom of the funnel. 
Together these observations provide important insights about the protein-
protein association reaction. 
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SYSTEMS BIOLOGY ANALYSIS OF A SMALL BACTERIUM: M. 
PNEUMONIAE 
 
Luis F Serrano  
 
Centro Regulacion Genomica, Systems Biology, Barcelona, 08003, Spain 
 
To understand basic principles of bacterial metabolism organization and 
regulation, but also the impact of genome-size thereon, we systematically 
studied one of the smallest bacteria, Mycoplasma pneumoniae. A manually 
curated metabolic network of 189 reactions catalyzed by 129 enzymes 
allowed the design of a defined, minimal medium with 19 essential 
nutrients. More than 1,300 growth curves were recorded in the presence of 
various nutrient concentrations. Measurements of biomass indicators, 
metabolites and 13C-glucose provided information on directionality, fluxes 
and energetics; integration with transcription profiling enabled global 
analysis of metabolic regulation. Compared to more complex bacteria, the 
M. pneumoniae metabolic network has a more linear topology and contains 
a higher fraction of multifunctional enzymes; general features such as 
metabolite concentrations, cellular energetics, adaptability and global gene 
expression responses are similar though. In parallel we have combined 
strand-specific tiling arrays, complemented by transcriptome sequencing, 
with more than 252 spotted arrays. We detected 117 previously 
undescribed, mostly non-coding transcripts, 89 of them in antisense 
configuration to known genes. We identified 340 operons, of which 140 are 
polycistronic; almost half of the latter show decaying expression in a 
‘staircase-like’ manner. Under various conditions, operons could be divided 
into 447 smaller transcriptional units, resulting in many alternative 
transcripts. Frequent antisense transcripts, alternative transcripts, and 
multiple regulators per gene imply a highly dynamic transcriptome, more 
similar to that of eukaryotes than previously thought. Finally we used 
Tandem Affinity Purification-Mass Spectrometry (TAP-MS) in a proteome-
wide screen. The analysis revealed 62 homomultimeric and 116 
heteromultimeric soluble protein complexes, of which the majority are 
novel. About a third of the heteromultimeric complexes show higher levels 
of proteome organization, including assembly into larger, multi-protein 
complex entities, suggesting sequential steps in biological processes, and 
extensive sharing of components implying protein multifunctionality. 
Incorporation of structural models for 484 proteins, single particle EM and 
cellular electron tomograms provided supporting structural details for this 
proteome organization. The dataset provides a blueprint of the minimal 
cellular machinery required for life. 
 13 
FROM BIOLOGICAL NETWORKS TO PHYLOGENY AND DISEASE 
 
Natasa Przulj  
 
Imperial College London, Department of Computing, London, SW7 2AZ, 
United Kingdom 
 
Genes produce thousands of different protein types that interact in complex 
networked ways and make cells work. It is possible that interaction network 
data will be as useful as the sequence data in uncovering new biology. 
Given the abundance of interaction data, systems-level comparisons of 
networks of pathogenic and non-pathogenic species could play a vital role 
in understanding mechanisms of pathogenicity. Also, comparing networks 
of healthy and disease-affected cells could deepen our understanding of 
disease and lead to identification of cellular parts that are candidates for 
therapeutic intervention. Furthermore, biological network comparison and 
alignment could enable transfer of knowledge between species, since we 
may know a lot about bio-molecules in one species and almost nothing 
about aligned bio-molecules in another species.  
 
Existing network alignment methods use information external to network 
topology, e.g., sequence data. Since network topology provides a new and 
independent source of biological information, it is important to understand 
how much biology we can learn from it independently from any other data 
source. Hence, we develop mathematically rigorous ways for aligning 
networks based solely on their topology. Our network aligners produce by 
far the most complete alignments of biological networks to date, exposing 
large and contiguous regions of network similarity even for as distant 
species as yeast and human thus suggesting broad similarities in internal 
cellular wiring across all life on Earth. Moreover, they demonstrate that 
protein function and species phylogeny can be extracted solely from 
network topology. Analogous to reconstruction of phylogenetic trees using 
sequence similarities, we use our network alignment similarities to 
successfully reconstruct the phylogenies of protists, fungi, and 
herpesviruses.  
 
In addition, we show that network topology around cancer and non-cancer 
genes is different and use this to predict new cancer genes. Our predictions 
are phenotypically validated. Next, we show that aging, cancer, and 
pathogen-interacting genes have topologically “central” roles in the 
network, as they form the “spine” of the network that connects all other 
network parts and is hence vital for normal cellular functioning. Also, we 
show that sequence and topology give insights into complementary slices of 
biological information and that network topology can be used as a 
complementary method to sequence-based homology identification.  
 
We present evidence that topology-based analyses of biological networks 
provide new biological and phylogenetic insights and that they can help 
identify novel drug targets, hence aiding therapeutics and health care.  
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A PROTEIN INTERACTION WIRING OF THE HUMAN 
SPLICEOSOME 
 
Anna Hegele1, Atanas Kamburov1, Crysovalantis Sourlis1, Arndt 
Grossmann1, Sylvia Wowro1, Mareike Weimann1, Vlad Pena2, Reinhard 
Lührmann2, Ulrich Stelzl1  
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Splicing of pre-messenger RNA is catalyzed by the spliceosome, which 
consists of the five U1, U2, U4, U6 and U5 RNAs and between 180 and 230 
proteins in human. On each mRNA the spliceosome assembles and 
disassembles afresh. This spliceosomal assembly cycle is a highly dynamic 
process. Well defined large RNP complexes are formed in an ordered, 
stepwise manner. For example a total of ~ 65 proteins exchange during the 
conversion of the B to the C complex, which encompasses catalytic 
activation. Both, RNA-protein and protein-protein interactions are crucial 
for the formation, rearrangements and dissociation of the complexes.  
We set out to systematically characterize human spliceosomal protein-
protein interactions. A yeast two-hybrid matrix screen examining all pair 
wise interactions between ~ 230 spliceosomal or spliceosome associated 
proteins, represented by ~ 430 cDNA clones, was carried out. The screen 
revealed more than 500 putative protein-protein interactions. Most of the 
interactions are novel; however about 30% of the current PPI knowledge in 
the literature was recapitulated. Selected protein-protein interactions are 
analyzed on the domain level and a large fraction of PPIs is being validated 
in co-immunoprecipitation experiments in mammalian cells. 
Computational analysis of the PPI network and integration with complex 
purification data provides novel insight into the spliceosomal assembly 
cycle. This includes e.g. hints to how the Prp19 complex is recruited to the 
B complex, the assembly of B-complex specific proteins or the interaction 
of step2 proteins such as hSlu7 or Prp16 with protein components of the 
core C complex. It also suggests important roles for some of the previously 
uncharacterized spliceosomal proteins. 
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PROTEIN COMPLEXES AND NETWORKS FOR GREEN BIOTECH 
 
Jelle Van Leene1, Dominique Eeckhout1, Geert Persiau1, Eveline Van De 
Slijke1, Erwin Witters2, Geert De Jaeger1  
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A central theme of todays plant biotech is the discovery of new genes or 
combinations of genes whose engineering can lead to crops with increased 
biomass production or resilience in sub-optimal environmental conditions. 
Building protein interaction networks forms an attractive new approach to 
find new knowledge for such applications. We developed a high throughput 
TAP technology platform for complex isolation from Arabidopsis cell 
suspension cultures and applied it to map the core complex machinery at the 
heart of the Arabidopsis cell cycle control. The resulting network offers for 
the first time a comprehensive view on CDK/cyclin complexes of a higher 
plant and contains over 100 new candidate cell cycle genes. Besides a 
central regulatory network of core complexes, we distinguished a peripheral 
network that links the core machinery to up- and downstream pathways. 
Furthermore, we could demonstrate that plants have evolved a 
combinatorial toolkit comprising at least a hundred different CDK/cyclin 
complex variants, which strongly underscores the functional diversification 
among the large family of cyclins and reflects the pivotal role of cell cycle 
regulation in the developmental plasticity of plants. Perturbation of a first 
set of the new candidate cell cycle genes lead to interesting phenotypes, 
showing larger biomass. 
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ANALYZING REGULATORY CIRCUITRY WITH EXPRESSION-
PROFILE PHENOTYPES 
 
Frank Holstege  
 
University Medical Center Utrecht, Genomics Laboratory, Utrecht, 3508 
AB, Netherlands 
 
The availability of whole genome sequences and the parallel development 
of various high-throughput techniques is making it possible to analyze and 
understand regulatory processes in a global manner. We are systematically 
generating DNA microarray mRNA expression-profiles of targeted 
mutations in components of the signaling and transcription machinery in the 
yeast S. cerevisiae. One of the first completed sets encompasses all 150 
non-essential protein kinases and phosphatases. Linear signal transduction 
pathways are readily identified by this approach as well as new cellular 
roles for previously uncharacterized kinases and in some cases direct 
kinase/phosphatase targets. Since one goal is to understand the entire 
regulatory circuitry active under a single condition, we have also 
systematically analyzed genetic redundancy, by profiling all kinase and/or 
phosphatase double-deletions that show negative synthetic genetic 
interactions. This reveals three different redundancy phenotypes: complete, 
quantitative and incongruent. Incongruency originates from partially 
redundant pairs that are coupled through additional regulatory links, and is 
the most frequently observed redundancy phenotype. Much of the 
redundancy involves non-homologs. This includes phosphatase-kinase 
redundancy, caused by phosphatase-mediated inhibitory cross-talk between 
kinase pathways. Mechanisms underlying incongruent phenotypes plausibly 
explain the evolutionary maintenance of genetically redundant pairs, based 
on superior combinatorial control potential involving modules of partially 
redundant genes linked by unidirectional repression or inhibition of each 
other. These pairs can be directly redundant paralogs or indirectly redundant 
non-homologs. Both form recurrent regulatory modules suitable for coupled 
and uncoupled regulation of different combinations of cellular responses, 
dependent on condition or context. The consequence of many such modules 
when wired together is the potential to deftly control a large number of 
completely different combinations of processes through different activity 
mixes of relatively few pathways. This suggests a common way in which 
combinatorial control is achieved through signaling.The results of profiling 
other sets of regulators such as chromatin remodellers and modifiers, will 
also be discussed. 
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EPISTASIS IN CONTEXT: UNDERSTANDING GENETIC 
INTERACTIONS THROUGH AN EXHAUSTIVE MODULAR 
DECOMPOSITION 
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Genetic interactions provide a powerful perspective into biological 
processes that is fundamentally different from other high-throughput 
genome-wide studies. Recently, Synthetic Genetic Array technology was 
used to produce the first genome scale map of digenic genetic interactions, 
which covered ~5.4 million genetic interactions or about ~30% of all 
possible gene pairs in yeast. This provides a first opportunity for a global, 
unbiased assessment of the structure of the genetic interaction network and 
the relationship between this structure and individual gene function.  
We developed a data mining approach based on association rule learning to 
exhaustively discover all block structures within the yeast genetic 
interaction network, producing a complete modular decomposition of the 
network. We find that genetic interaction hubs can be clearly differentiated 
into distinct classes of hubs based on their modular structure and that these 
distinctions correspond to date and party hubs previously observed in 
protein-protein interaction networks. Moreover, module membership 
provides a specific and unbiased assessment of the prevalence of multi-
functionality among genes: we find that genes participate in far more 
functions or contexts than was previously appreciated. In addition, we find 
that genetic interactions contained within structured modules exhibit 
strikingly different functional properties relative to isolated interactions, 
providing insight into the evolution and functional divergence of duplicate 
genes. Finally, the modular structure of the genetic interaction network 
gives surprising evidence both for and against the traditional between-
pathway and within-pathway models of genetic interactions. 
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FUNCTIONAL GENE NETWORK OF A PATHOGENIC BACTERIUM; 
PSEUDOMONAS AERUGINOSA 
 
Sun-Gou Ji, Insuk Lee  
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Due to their simple growth requirements and nutritional versatility, 
members of the genus Pseudomonads are ubiquitous organisms that can 
grow in virtually any environment and gain resistance from many 
antibiotics. The best-known of them - Pseudomonas aeruginosa, has been 
reported as one of the most frequent cause of nosocomial infections, as well 
as the predominant cause of morbidity and mortality in cystic fibrosis 
patients. However, the mechanisms of its pathogenesis and antibiotic 
resistance have not been completely understood yet.  
Here, we present a genome-scale functional network of P. aeruginosa genes 
reconstructed by integrating currently available data directly derived from 
P. aeruginosa, as well as from other bacteria such as E. coli, H. pylori, etc. 
Novel interactions could be inferred through the guilt-by-association 
method using various kinds of binary associations such as functional 
genomics, proteomics and comparative genomics data sets. These included 
DNA microarray co-expression datasets downloaded from GEO by NCBI 
and ArrayExpress by EBI, and protein-protein interactions from small scale 
experiments databases such as DIP, BOND, IntAct, MPIDB, etc. 
Furthermore, large-scale TAP-MS, LCMS, MALDI-TOF or Yeast 2-hybrid 
experiments of various bacterial species from published literatures were 
processed and integrated into the network. In addition, interactions from 
phylogenetic profiles and genomic context similarities where also included, 
plus, associations transferred from yeast, worm, human and A. thaliana 
genes from previously constructed networks were incorporated.  
Similar modeling approaches have already been successfully applied to 
intensively studied model organisms such as, S. cerevisiae, C. elegans, A. 
thaliana, etc, but this time, a bacterial pathogen was subjected to this 
approach. The system-level functional network model of the genome of P. 
aeruginosa would open new avenues to unravel the underlying interplay 
among genes involved in bacterial pathogenesis, and lead to a further 
comprehension of functional genomic interactions between a pathogen and 
its host.  
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WHY WOULD A MUTATION KILL ME, BUT NOT YOU? 
 
Ben Lehner  
 
EMBL-CRG Systems Biology Unit and ICREA, Centre for Genomic 
Regulation, Barcelona, 08003, Spain 
 
Mutations do not always have the same effect in different individuals. For 
example, most "disease mutations" in humans do not actually cause disease 
in all (or even most) of the people who carry them. What are the reasons for 
this? One aspect is, of course, the environment. Another aspect is, however, 
the "genetic environment" and we have been using C. elegans as a model 
system to understand - and to learn how to predict - how mutations combine 
epistatically to cause phenotypic change. Based on this work we are now 
also addressing the problem of non-genetic variation in mutation outcome. 
That is, we are dissecting the stochastic inter-individual differences that 
determine whether an individual is affected by a mutation or not. 
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SOX9-DIRECTED GENE REGULATORY NETWORK CONTROLLING 
MURINE EMBRYONIC SKELETAL DEVELOPMENT 
 
Sook Peng Yap, Thomas Lufkin  
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Sox9 is critical for embryonic chondrogenesis and skeleton formation, yet 
few direct target genes are known, limiting our understanding of this 
biological process. We reveal here for the first time a highly detailed gene 
regulatory network (GRN) anchored by Sox9. Expression profiling of 
wildtype, heterozygous and null Sox9 cells isolated from staged living 
embryos, identified 6124 differentially expressed genes as Sox9 
“downstream” targets. In situ hybridization validated key targets, including 
Col2a1, Matn4 and Hapln1. In parallel Sox9 chromatin 
immunoprecipitation-sequencing (ChIP-Seq) mapped the Sox9 binding 
genomic loci. Along with the canonical Sox9 binding motif, we also 
identified 2 novel Sox9 motifs and further confirmed their direct binding 
and regulation by Sox9. The integration of gene expression profiling and 
Sox9 DNA binding data has enabled us to identify a set of Sox9 direct and 
in-direct target genes and successfully led to the elucidation of the Sox9-
directed GRN controlling mammalian skeletogenesis. 
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FUNCTIONAL VS. TOPOLOGICAL PREDICTIONS OF ESSENTIAL 
GENES OF THE FOOD-BORNE PATHOGEN CAMPYLOBACTER 
JEJUNI 
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Baranyi  
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The emergence of network science has raised the question of whether the 
topology of the networks of genes or substrates in a cell could explain its 
functions. One such function is the determination of essential genes; those 
that are indispensible for growth under laboratory conditions. The highest 
accuracy of predicting essential genes in micro-organisms in a given 
environment is obtained with functional analysis such as Flux Balance 
Analysis (FBA), where 90% of essential genes may be predicted for the 
most studied micro-organisms such as E. coli (Feist et al., 2007, Mol 
Systems Biology, 3:121). These predictions are only matched in terms of 
accuracy by the topological network analysis of the “synthetic accessibility” 
(Wunderlich and Mirny, 2006, Biophys J, 91:2304-11). This method may 
also be classified as functional analysis since it analyses the metabolic 
network where the purpose is the production of substrates. Topological 
networks, such as the Protein-Protein interaction network can point to gene 
essentiality though analysis of hubs and bottlenecks (Jeong et al., 2001, 
Nature 411:41-42, Yu et al., 2009, PLoS Comput Biol 3:e59). However, it 
remains difficult to predict essential genes from such a network with 
accuracy. Other indicators such as the connectivity of a “molecular 
network” have also been investigated to determine essential genes (del Rio 
et al., 2009, Systems Biol, 3:102).  
For micro-organisms other than the established paradigm model systems, 
reconstruction of metabolic network is more delicate and the accuracy to 
predict essential genes by established methods like FBA is much lower. In 
order to predict essential genes in the food-borne pathogen Campylobacter 
jejuni, we have reconstructed a genome scale metabolic network based on 
published genome annotations and on-line databases such as BioCyc and 
KEGG. The genome of this pathogen is small (about a third of E. Coli’s) 
and presents some hypervariable sequences in genes linked to the surface 
structure (Parkhill et al., 2000, Nature, 403:665). While its central 
metabolism has been studied to some extent, much remains to be known 
concerning the composition and biosynthesis of the cell wall and capsule 
surrounding the cell. The network was validated against BIOLOG 
experimental data (Line et al., 2010, J. Microbiol. Methods, 80:198-202). 
We have drawn evidence from FBA, analysis of the Protein-Protein 
interaction topology (Parish et al., 2007, Genome Biol 8:R130), and 
experimental transposon mutagenesis to make predictions about essential 
genes in this pathogenic organism.  
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PROTEIN NETWORKS REVEAL DETECTION BIAS AND SPECIES 
CONSISTENCY WHEN VIEWED THROUGH INFORMATION--
THEORETIC GLASSES. 
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Protein–protein interaction networks (PPIN) are the backbone of cellular 
function and allow for the identification of several biological processes, 
such as important pathways and macromolecular complexes. Apart from the 
evident biological information provided by PPIN, they also provide a series 
of topological properties such as degree distributions, assortativity, average 
degree, clustering coefficient, etc. Among many other useful purposes for 
the use topological information, is the direct comparison of networks either 
between different species or between networks of the same specie obtained 
by different experimental techniques. Most studies so far have fallen short 
of a realistic topological comparison between networks, this mainly due to 
the fact that only degree distribution have been used for such comparisons.  
We apply a series of rigorous mathematical methods, which we have 
recently developed, to the topological exploration of several PPIN available 
in the public domain. We first apply a systematic analytical framework with 
which to quantify the macroscopic topological structure of PPIN along with 
the generation of reliable ‘null models’ (random graphs whose topological 
features can be controlled precisely). We calculate entropy measures that 
relate to network complexity. We define complexity according to the 
uniqueness of a network when compared to an equivalent null model 
network. Alongside those calculations we also developed methods that 
determine differences between networks purely based on topological 
properties and apply those methods to perform a species to species 
comparison. Although the availability of datasets with adequate coverage 
and of high accuracy is lagging, we have now created the necessary tools 
for a detailed topological characterization and direct network comparisons. 
 
 
Annibale A., Coolen, AAC, Fernandes, LP, Fraternali, F, Kleinjung, JK. 
Tailored Graph Ensembles as Proxies or Null Models for Real Networks I: 
Tools for Quantifying Structure. 
Journal of Physics A: Mathematical and Theoretical 2009 42 485001.  
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REDUCING REDUNDANCY IN BIOLOGICAL NETWORKS 
 
Mochamad Apri1,2, Jaap Molenaar1,2, Simon van Mourik1, Maarten de Gee1  
 
1Wageningen University, Biometris, Wageningen, 6708PB, Netherlands, 
2Netherlands Consortium for Systems Biology, CWI, Amsterdam, 1090GE, 
Netherlands 
 
Most biological networks are very complex and may consist of hundreds to 
thousands components with intricate interactions. If we describe the 
dynamics of such networks in terms of ordinary differential equations, we 
are faced with the challenge to solve a very large nonlinear system of 
equations. Although such detailed models may lead to accurate predictions, 
their complexity is a serious disadvantage in several respects, e.g, the large 
computing times may obstruct the efficient estimation of parameters. 
Moreover, the interpretation of the behavior of huge networks may be hard. 
Since the dynamics of networks is often dominated by only a subset of the 
nodes and the interactions, it is very useful to develop methods that can 
detect redundancy in a given network and delivers a reduced network that 
still captures the key features of the dynamical behavior of the original 
network.  
 
Here, we present a method to systematically reduce redundancy in a 
biological network and thus simplifies the biological interpretation of the 
dynamics of the original network. The method is based on a sensitivity 
analysis approach that has successfully been applied in combustion 
engineering problems. This approach has been adjusted to account for 
nonlinearities that may stem from, e.g., Michaelis-Menten dynamics. The 
idea is to remove redundant nodes and redundant interactions from the 
network. As a first step, one identifies an initial set of nodes that play a 
crucial role in the network. Then, the sensitivities of the dynamics of these 
nodes to the dynamics of the rest of the nodes are evaluated. Nodes that turn 
out to be important for the crucial nodes are then considered as crucial and 
added to the set of crucial nodes. After that the sensitivities are recalculated. 
This step is repeated until two complementary sets of nodes are found, one 
of crucial and one of redundant nodes. By removing the redundant nodes a 
reduced network is obtained. Next, this reduced network is checked on the 
presence of redundant interactions by calculating the so-called “rate 
sensitivity matrix”. The eigenvalues and the eigenvectors of this matrix give 
a way to order the parameters in increasing importance and to remove non-
essential interactions. Eventually, we obtain a reduced biological network 
that still preserves the important features of the full network.  
 
For illustrational purposes, the method is first applied to a small artificial 
network. Then, we apply it to a large network model underlying the cell fate 
determination in the floral meristem of Arabidopsis Thaliana and show that 
this model allows considerable reduction. 
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ARCHITECTURES AND INTERACTIONS OF BBSOME AND IFT 
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Nearly every cell in the human body has primary cilia, striking antenna-like 
projections with a microtubule core that are required for diverse sensory 
functions including phototransduction, olfaction, planar cell polarity and 
morphogen signaling. Targeting of transmembrane receptors to the tip of the 
cilium is critical for proper sensing and transduction of signals, and the 
molecular machinery responsible for their sorting and trafficking has been 
discovered to be a series of large protein assemblies. One of these involves an 
octameric complex of proteins genetically linked by mutation to Bardet-Biedl 
Syndrome (a group of severe human developmental disorders caused by ciliary 
dysfunction) and is called the BBSome. The structural anatomy of the BBSome 
has been explored with sensitive fold recognition, structure prediction and 
modeling tools, and reveals an economical architectural toolkit that is 
remarkably similar to COPI, COPII and clathrin coat complexes. Notably, 
BBS4 and BBS8 are almost entirely comprised of helical TPR-class repeats and 
are predicted to form rigid, rod-shaped α-solenoid structures. By contrast, we 
show that BBS1, BBS2, BBS7 and BBS9 have a common domain architecture 
distinguished by a toroidal β-propeller fold with an appendage segment similar 
to those found in several clathrin adaptors and in coatomer; this appendage 
domain is typically comprised of two protein recruitment modules, an Ig-like β-
sandwich γ-adaptin ear (GAE) motif coupled to an α/β platform structure. The 
most conserved subunit, BBS5, contains distant pleckstrin homology (PH)-like 
folds that bind phosphoinositides and associate BBS5 with membranes; BBS3 is 
the small Arf-like GTPase Arl6 and most likely involved in the recruitment of a 
coat-like complex to membranes. In the present work, we contrast the fold 
architecture and emerging interaction map of the BBSome coat-like scaffold 
components with those of the two very large intraflagellar transport (IFT) 
multiprotein complexes A and B that are critically involved in movement of 
membrane ciliary cargo by engaging molecular motors that travel up and down 
the microtubule axoneme.The final compendium of protein folds dedicated to 
serve as struts and joints of coat-like assemblies (the helical solenoid rods and 
β-propeller toroids, respectively), or as specialized interaction and targeting 
modules (like the appendage and PH domains in the BBSome, or novel 
calponin-like domains in IFT proteins) should help clarify the evolutionary 
emergence and retained (or divergent) molecular functions of BBSome and IFT 
subunits. Key to these comparative structural studies are interaction maps that 
aid in the spatial packing of modular components, and also identify symmetric 
subcomplexes within BBSome and IFT systems that may represent both 
evolutionary relics and smaller functional machines active outside ciliary 
transport. 
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Seed development is coordinated with synthesis and deposition of storage 
products in many plant species. The complex interconnected regulatory 
programs involving the embryo development and metabolism that define 
qualitative and quantitative aspects of seeds are largely unknown. To 
address this critical gap, we have used integrated systems approach and 
generated large genomic, proteomic and metabolomic datasets for key 
stages of embryo development in model plant Arabidopsis. Analysis of 
these datasets provided critical frame work to develop metabolic network 
models. To test the biological implications of these models, two putative 
regulatory nodes associated with fatty acid and carbohydrate synthesis are 
selected and the associated genes encoded by “ACC1” and “Epimerase” 
have been investigated using loss and gain of function studies. Genetic 
lesions in both loci independently lead to embryo lethality with significant 
down regulation of genes connected to the affected nodes. Further, in acc1 
mutant line, the production of a number of fatty acids including long chain 
is severely affected and interestingly increased the levels of some of the 
carbohydrates. Similarly, in epimerase mutant line, the production of some 
of the carbohydrates significantly reduced with increase in the synthesis of 
some fatty acids. Consistent with these observations, Epimerase over 
expression in the seeds showed reduction in the overall oil content. 
Together, these studies provide important regulatory connections between 
the synthesis and deposition of carbohydrates and lipids, the two major 
storage products in the seed. Thus, our results provide direct evidence and 
insights into metabolic network models in Arabidopsis seed. 
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Short, linear motifs (SLiMs) play a critical role in many biological 
processes, particularly in protein–protein interactions. The SLiMFinder 
(Short, Linear Motif Finder) web server is a de novo motif discovery tool 
that identifies statistically over-represented motifs in a set of protein 
sequences, accounting for the evolutionary relationships between them. 
Motifs are returned with an intuitive p-value that greatly reduces the 
problem of False Positives and is accessible to biologists of all disciplines. 
Input can be uploaded by the user or extracted directly from UniProt. 
Numerous masking options give the user great control over the contextual 
information to be included in the analyses, including evolutionary 
conservation and protein disorder prediction. The SLiMFinder server 
combines these with user-friendly output and visualisations of motif context 
to allow the user to quickly gain insight into the validity of a putatively 
functional motif. These visualisations include alignments of motif 
occurrences, alignments of motifs across homologous sequences and a 
visual schematic of the top-ranked motifs. Returned motifs can also be 
compared to known SLiMs from the literature using CompariMotif. All 
results are available for download.  
 
In addition to the main SLiMFinder webserver, additional recent 
developments of methods and resources for SLiM discovery will be 
outlined. 
 
The SLiMFinder server is available at: 
http://bioware.ucd.ie/slimfinder.html. 
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Proteins are essential for all kinds of biological processes. They usually act 
in concert by forming pairwise interactions or complexes through functional 
subunits such as protein domains. Tissue-specific gene expression can lead 
to the presence or absence of proteins, resulting in the gain or loss of protein 
interactions and complexes in certain tissues. Over the last years, several 
studies have been performed aiming at the identification of universal and 
tissue-specific gene expression and their functional implications. These 
studies were commonly based on extensive microarray data such as the 
Novartis Gene Atlas. Microarrays, however, have the drawback that they 
cannot accurately measure gene expression at low levels. This may lead to 
the misclassification of low expressed genes as absent, which introduces a 
bias towards high expressed genes into molecular studies. 
With the advent of second-generation RNA-sequencing techniques, it is 
now possible to sequence complete transcriptomes and measure gene 
expression with higher accuracy. Therefore, we used publicly available 
RNA-sequencing data for fifteen tissues and cell lines to identify universal 
and tissue-specific expression of proteins, protein interactions, protein 
domains, and complexes. Our results show that by far fewer protein 
interactions are tissue-specific than previously thought. Our Gene Ontology 
analysis indicates that tissue-specific interactions are highly enriched in 
receptor and transmembrane activities, with substantial differences in the 
numbers of specific interactions among all tissues and cell lines. 
Furthermore, we investigated the tissue-specificity of protein domains. We 
collected all genes encoding a certain domain and computed the average 
number of tissues per domain according to the gene expression. 
Interestingly, our results show that only few domains are tissue-specific. 
Furthermore, our results indicates that a high percentage of these tissue-
specific domains mediate protein-DNA interactions rather than protein-
protein interactions, which is also confirmed by GO enrichment analysis. In 
addition, we find that most known protein complexes obtained from 
CORUM and PDB are completely expressed (i.e. all co-complexed proteins 
are expressed) in all tissue and cell line samples, regardless of the complex 
size. In contrast, a closer examination of only tissue-specific complexes 
suggests that tissue-specific protein complex formation is frequently 
controlled by one or few tissue-specific proteins, while the majority of co-
complexed proteins are universally expressed. Overall, our new insights are 
of great relevance not only for studying gene expression, protein functions, 
and protein interactions, but also for analyzing diseases and possible drug 
targets. 
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The inference of causal interactions from high-throughput data is important 
because the analysis of the resulting networks may provide novel insights 
into the functioning of the underlying molecular system. Despite its 
importance, the systematic analysis of statistical and computational 
approaches is still in its infancy. Our contribution consists of two parts. 
First, we address the question of experimental design and discuss various 
evaluation measures. Specifically, we study network-based evaluation 
measures in combination with ensemble data. Second, we discuss a novel 
inference methods, C3NET, and present results from a comparative study.  
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Background: It is well known that disease-causing genes (and drug-
targeted genes) are more likely to interact with each other in the interactome 
network. However, there is lack of an analysable framework to 
systematically exploit connections between diseases and drugs.  
Methodology: Here, we report a network-oriented approach to identify all 
the possible components of the connections between diseases and drugs. We 
reason that these high-level relationships among diseases and drugs are 
principally encoded in the gene-level topological structure of the compiled 
human gene network. The strength of relationships can be measured by the 
observed links against the expected links under the binomial distribution-
based model. Specifically, we first classified diseases from OMIM database 
into 22 main disease categories based on the organ system affected, and 
drugs from DrugBank database into 14 main drug groups according to the 
Anatomical Therapeutic Chemical classification system. Then, we 
quantified the topological relationships between disease genes and drug 
targets in the human gene network, resulting in interconnectedness matrix 
between/within OMIM diseasome categories and DrugBank drug groups.  
Results and Discussion: As expected, genes causing the same type of 
disease or targeted by same group of drug are significantly linked together 
in the network. Inspections of the disease-disease block show that high 
interconnectivity is biased towards the most common diseases (i.e., 
respiratory, hematological, endocrine, cancer, and immunological disease 
classes), forming a fully interconnected clique. Others are less 
interconnected. Co-existence of the disease clique and less-interconnected 
disorders reflects the underlying evolutionary constraints on pathogenesis. 
Further inspections of the drug-drug block show that all of drugs are highly 
interconnected to form a drug clique, partially indicating the current 
practices of using off-target drugs to combat the diseases. Interestingly, the 
drug clique tends to interconnect the disease clique, further indicating that 
the drug clique probably occurs during the efforts against these most 
common diseases in disease clique. A closer inspection of connections 
between drug and disease, both associated with the same category, shows 
that the successful on-target efforts in disease clique compromise the off-
target consequences. These observations call for the more rational drug 
design to maximize the efficiency while minimizing the side effects.  
 
Keywords: Network; interconnectedness; diseases; drugs 
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Down syndrome (DS), trisomy of human chromosome 21 (HSA21), is 
characterized by an average IQ of 45, and a constellation of 
learning/memory deficits implicating hippocampal dysfunction, in 
particular spatial learning. The phenotype is caused by the increased 
expression, due to gene dosage, of human chromosome 21 (HSA21) genes 
that include 160 protein coding genes and an additional 350 genes of 
unassigned function. To address this complexity, with the goal of 
identifying potential targets for pharmacoptherapies, we have implemented 
comprehensive pathway analysis, combining information on protein-protein 
interactions, genetics of intellectual disability (ID), drug-induced gene 
expression responses, and experimental analysis of mouse models of DS. 
Curated pathways from multiple databases (KEGG, Reactome, PID) were 
scored based on the number of HSA21 components, the number of HSA21 
primary interactors (obtained from HPRD, BIND, BioGRID), and on the 
number of additional components known to cause ID when mutated (based 
on evidence in OMIM and the literature). The highest scoring pathways are 
those most likely to be perturbed in DS and to contribute to ID in DS. 
Predictions of pathway perturbations are tested in cell lines and brains of 
mouse models of DS that are trisomic for partially overlapping subsets of 
HSA21 orthologs and that display learning/memory deficits relevant to DS. 
We use the moderate through-put technique of Reverse Phase Protein 
Arrays, to generate protein profiles of HSA21 proteins and candidate 
phosphorylated and non-phosphorylated pathway components. Drugs that 
alter the expression of HSA21 genes and that impact high scoring pathways 
were identified from the Connectivity Map (The Broad Institute) and 
PubChem. Mouse models are being treated with candidate drugs and tested 
for corrections of abnormalities in the protein profiles and behavior. 
Computational methods are used to predict behavior from protein profiles 
and to identify the most significant protein abnormalities in DS models. We 
have identified perturbations in pathways involving NMDA receptor, 
calcineurin and MAP kinase signaling, oxidative stress and apoptosis. 
Machine Learning Methods have successfully predicted locomotor 
responses to MK-801 and memantine has corrected subsets of protein 
profile abnormalities in the major mouse model of DS. Pathway analysis 
can help to overcome the limitations of mouse models of DS and improve 
success rates in selecting drugs for preclinical evaluations. 
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Precise control of the translation machinery underpins the capacity for the 
growth and selective competitiveness of living organisms, and therefore the 
quantitative properties of the overall system and the evolution of its 
molecular components are tightly coupled. Here, we identify the system-
level control features of the entire eukaryotic translation pathway, thus 
identifying the contributions of all of the known yeast translation factors 
and defining the quantitative meaning of translational control. The highly 
non-stoichiometric in vivo complement of translation components is found 
to form an exquisitely balanced system in which no single factor or step is 
uniquely limiting or in excess of optimal system requirements. To 
summarize the key aspects of control, we have also incorporated our data 
into an in silico mathematical model of translation covering initiation, 
elongation and termination. A quantitative measure of system-specificity 
reveals how these proteins share their commitment across multiple cellular 
pathways. The comprehensive quantitative control map obtained for this 
modular gene expression system opens a new window on the adaptive 
consequences of collective molecular evolution. 
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The Baculoviruses are important bio-control agents and biological vectors. 
Despite insights into their genome structure from sequencing studies, our 
understanding of gene regulation, interaction and function is limited. We 
use an evolutionary approach to reconstruct gene regulatory networks 
(GRNs) in baculovirses. We test the hypothesis that baculovirus gene 
function can be predicted by combining phylogenetic data and gene 
regulatory modules. All baculoviruses share a core set of twenty-nine genes 
involved in replication and transcription, suggesting common pathways for 
these vital functions. Gene expression in baculoviruses is also highly 
regulated and occurs in successive phases divided into early, late, and very 
late genes. In addition, phylogenetic analyses have demonstrated that the 
process of gene acquisition and gene loss are important factors in 
baculovirus evolution. We assess functional categories and analyze the 
dynamics of gene gain and loss along the phylogenetic tree of individual 
baculoviruses. Gene expression data was applied to reconstruct a phylogeny 
tree based on clusters of late expression genes of the Autographa californica 
multinucleocapsid virus (AcMPNV). We applied a maximum parsimony 
method that produces a phylogenetic classification that recognizes delimited 
clades shared by derived gene expressions of AcMPNV. We then 
established a phylogenetic gene cluster of expression genes to infer a 
topological relationship within AcMPNV genes. The derived tree showed 
one large inclusive clade that encompassed all of the late expression genes. 
The results provide the information necessary to predict functional gene 
links and contribute to our understanding on the regulators of late 
transcription. The GRN provides an informative predictive model for the 
identification of baculovirus gene function using phylogeny and expression 
profiles. 
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We have systematically mapped the interactions of several influenza virus 
strains with host cells and integrated these results with data from genome-
wide siRNA screens. Host proteins binding to viral proteins were identified 
by large-scale yeast two-hybrid (Y2H) screening. 111 protein-protein 
interactions were identified. 46 of the interactions were re-tested in 
LUMIER assays with a confirmation rate of 42%. Interactions were highly 
similar between viral strains, and overlapped to a small but significant 
extent with published interactions. Recently, five papers reported the results 
of genome-wide siRNA screens for proteins required for influenza virus 
replication. The extent of overlap between the host cell proteins identified 
in our yeast two hybrid data with those found in the siRNA is highly 
significant, and comparable to the overlap of the siRNA screens amongst 
each other. GO-term analysis shows that host cell proteins identified by 
siRNA screens and protein interaction studies are in part enriched in the 
same processes, namely protein folding, intracellular transport, RNA 
processing, cell cycle regulation and signal transduction. Several of the 
newly reported interactions provide molecular explanations for the 
identification of particular genes in siRNA screens. For example, siRNA 
screens identified ARCN1 as a host cell factor necessary for viral infection. 
ARNC1 is part of the COPI complex involved in early to late endosome 
transport vehicle formation. siRNAs vs ARCN1 and COPG blocked 
infection. The observation that ARCN1 binds to the viral protein M1 
provides a molecular basis for this genetic interaction. 
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One of the challenges of modern functional genomics is to understand 
genetic 
determinants and networks that affect quantitative and qualitative aspects of 
the RNA transcription.We use the BXH/HXB rats - one of the most popular 
models for human hypertension. The advent of next generation sequencing 
enables us to generate genome-wide maps of genomic variants and 
expression 
profiles at base-pair resolution. 
 
The RNA-Seq expression profiling was performed in liver and brain tissues 
using replicates from 3 animals each. Both normotensive BN-Lx and 
hypertensive SHR were investigated for differences in expression change. 
We 
scored differences in gene expression, exon usage and splice forms between 
these rats. 
 
Based on correlation of expression data we have constructed regulatory 
gene 
networks for BN and SHR rats. Comparative analysis of these will help to 
detect genomic variants and biological pathways that determine phenotypic 
differences between the strains used and may provide insight in 
mechanisms 
underlying common human disease. 
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Proteomic studies have shown that thiazolidinedione (TZD) PPARγ agents 
stimulate changes in mitochondrial mass and morphology of 3T3-
L1adipocytes. Using an integrated physiology approach focusing on 
metabolic flux assessments and lipidomic profiling, we examined 
glycolytic, pentose and TCA metabolic pathways during 3T3-L1 
differentiation to adipocyte, and how this was potentiated by the 
administration of the TZD rosiglitazone (rosi). 3T3-L1 cells were treated by 
the protocol from the Orphan nuclear Receptor Consortium, with induction 
for 2 days, and then differentiation medium with insulin ± rosi. 
Morphologic changes resulting from rosi were seen only from day 6. Using 
2H2O assessment of protein synthesis, insulin + rosi significantly increased 
the rate by day 3 and the lipogenic rate by day 5. Measurements using the 
Seahorse XF96 Extracellular Flux analyzer showed rosi + insulin induced 
higher metabolic rates compared to insulin alone, with 40-50% increases in 
OCR by day 3 and in ECAR at day 4. This suggested increased 
mitochondrial function in the TZD treated 3T3-L1 adipocytes. Lipidomic 
studies, using a Thermo LTQ linear ion trap, showed that cardiolipin, an 
exclusive mitochondrial lipid, increased significantly by day 3 only in the 
rosi treated cells, suggesting that TZDs potentiate both mitochondrial mass 
and function. After induction, [1,2-13C]glucose flux studies showed that 
TCA glucose oxidation, as the proportion of anapleurotic TCA cycle flux, 
decreased in insulin + rosi treated cells, on days 3, 4 and 5 and was 
coincident with the increase in 2H2O assessment of the lipogenic rate in 
that interval. TCA glucose oxidation was increased on days 6-10 with 
rosiglitazone treatment, while TG content remained constant. 
Triacylglycerol species (TGAs) accumulated also increased notably under 
rosiglitazone treatment, from 30-100 fold by day 3. The increased TGAs, 
despite increased accumulation of ceramides, suggest the stimulation of 
insulin action by rosi. In conclusion, the combined use of metabolomics, 
lipidomics, fluxomics and bioenergenics can detect a series of metabolic 
effects induced by rosiglitazone much greater, and sooner, than significant 
morphological effects are seen. TZDs may alter mitochondrial energetics to 
foster biosynthesis by using mitochondrial fuel switching to maximize TG 
storage. This combined -omic approach may be useful for screening drug 
agents designed to affect bioenergenics or fat storage. 
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In order to understand the molecular basis of salt-stress response in 
grapevine plants, suppression subtractive hybridization (SSH) and 
microarray based screening approaches were combined. Two leaf-specific 
subtractive cDNA libraries were constructed from grapevine plants 
subjected to salt stress treatment. SSH were performed 6 and 24 h after 
addition of 100 mM NaCl in the nutritional solution using cDNAs prepared 
from leaves of a salt tolerant cultivar (Razegui) as testers and cDNAs from 
unstressed leaves as drivers. A pre-screened subset of cDNA clones from 
these SSH libraries were used to construct a Vitis vinifera cDNA array, in 
order to monitor the expression changes of the genes upon salt treatment. 
Expression profiles were compared between the salt-tolerant and a 
susceptible cultivar (Syrah) under both control conditions and after salt 
stress treatment. Seven cDNA clones were identified which were up-
regulated by salt stress and confirmed by RNA blot analysis. The transcript 
expression patterns of the selected genes differed between the contrasting 
grapevines cultivars were tested with respect to stress-regulation. 
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Discovering novel disease genes is still challenging for diseases for which 
no prior knowledge - such as known disease genes or disease-related 
pathways - is available. Performing genetic studies frequently result in large 
lists of candidate genes of which only few can be followed up for further 
investigation. We have recently developed a computational method that 
identifies the most promising candidate genes by replacing prior knowledge 
by experimental data of differential gene expression between affected and 
healthy individuals (Nitsch et al. 2009, PlosOne 4(5): e5526).  
To improve the performance of our prioritization strategy, we have 
extended our previous work by applying different machine learning 
approaches that identify promising candidate genes by determining whether 
a gene is surrounded by highly differentially expressed genes in a functional 
association or protein-protein interaction network.  
Our novel ranking strategies, scoring disease candidate genes, rely on 
network-based machine learning approaches, such as kernel ridge 
regression, heat kernel, and Arnoldi kernel approximation. For comparison 
purposes, a local measure based on the expression of the direct neighbors is 
also computed. We have benchmarked these strategies on 40 publicly 
available knockout experiments in mice, and performance was assessed 
against results obtained using a standard procedure in genetics that ranks 
candidate genes based solely on their differential expression level. Our 
results showed that our four strategies could outperform this standard 
procedure and that the best results were obtained using the heat kernel 
approach leading to an average ranking position of 8 out of 100 genes, an 
AUC value of 92.3% and an error reduction of 52.8% relative to the 
standard procedure approach which ranked the knockout gene in average at 
position 17 with an AUC value of 83.7%. 
 
Conclusion: In this study we could identify promising candidate genes 
using network-based machine learning approaches even if no knowledge is 
available about the disease or phenotype. 
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More than 25 years after its discovery, the Human Immunodeficiency Virus 
1 (HIV-1) is still one of the major threats on human life. Most anti-HIV 
drugs currently in use inhibit the catalytic activities of viral enzymes. 
However, a promising alternative is to target the interactions between viral 
proteins and host cells. In order to understand the complex interplay 
between HIV and its host, we have performed a comprehensive large-scale 
yeast-two hybrid study with all HIV-1 proteins as baits, using highly 
complex oligo_dT and random-primed cDNA libraries from the CEMC7 T 
cells line. A total of 34 screens resulted in the identification of 367 different 
host proteins. The interaction network was further densified by rebound 
screens with human proteins against a random-primed HIV-1 library. Here, 
we present an in depth analysis of our comprehensive HIV - human 
interactome and compare this network with the literature protein interaction 
data. In addition, we will demonstrate our sophisticated PIMRider software 
that allows straightforward analysis and navigation inside complex 
networks combining interaction, genetic and expression data from different 
sources. 
 39 
PATHWAY RECONSTRUCTION WITH CELL-TYPE-SPECIFIC CO-
EXPRESSION PROFILES IN ARABIDOPSIS ROOT 
 
Taeyun Oh, Insuk Lee  
 
Yonsei University, Life Science and Biotechnology, Seoul, 120-749, South 
Korea 
 
How plant adapt to ever changing environment is a major question in plant 
biology. For better understanding of transcriptional regulations relate to 
phenotypic change, a variety of high-throughput genome-wide gene 
expression profiling had been conducted. 
 
Multicellular organisms, however, reveal different transcriptional 
expression patterns in each cell-type. This cell-type specific transcriptional 
variation leads to the differential regulation of specific biological functions 
in subsets of cell layers, several of which correspond to recognizable 
physiological changes. 
 
If we profile gene expression in whole tissue containing heterogeneous cell 
types, only cell-type independent expression response will be recognized 
but cell-type specific expression response could be buried by confounding 
effect derived from different cell-types. 
 
With high-resolution root transcriptome profiling with various abiotic stress 
conditions and its tissue-level transcriptome control, we may compare 
effectiveness of pathway reconstruction between by whole-tissue expression 
profiles and by cell-type specific expression profiles. 
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In the past few years, we have learnt a lot about regulatory networks within 
the cell. While the entire physical and genetic interactomes have been 
extensively explored, both experimentally and computationally, relatively 
little experimental data is available for protein-mRNA interactions. 
Although the complex network of RNA-binding proteins and their targets 
plays an important role in gene expression control, interactions are known 
for only approximately 40 proteins in S. cerevisiae. 
 
In this study, we first perform an analysis of the available data, showing that 
RNA-binding proteins tend to bind the cognate mRNAs of their protein 
interaction partners and that proteins that share an mRNA target are more 
likely to physically interact. We then assemble a database of features of 
both the proteins and their mRNA targets to examine their relationships. We 
include functional characterization through Gene Ontology terms as well as 
properties at the mRNA level (such as UTR characteristics, mRNA 
structure, translational properties, expression levels) and features of the 
protein (such as amino acid composition and physico-chemical properties). 
Besides numerous correlations amongst features of a single gene, we 
identify relationships between features of the protein and of its target, with 
the main finding that proteins with a higher isoelectric point tend to bind 
longer transcripts. Using the available protein-mRNA interaction data and 
an assembled randomized negative set as training, we combine the collected 
features in a Support Vector Machine to predict protein-mRNA interactions 
in budding yeast. 
 
We achieve an estimated accuracy of around 70% in predicting targets of 
proteins for which some other mRNA targets are known, encountering a 
limitation of the method where there is no previous knowledge available on 
any of the protein’s targets. Finally, we extend the method to predictions of 
fission yeast protein-mRNA interactions. 
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Kinases have a fundamental role in a great number of biological processes. 
However, a complete picture of the molecular networks associated to this 
class of proteins is still missing. Although the use of large scale proteomic 
approaches is of great value to draw such a map, one main criticism is that 
data reproducibility is generally low and too much dependent on the 
variability of certain parameters, such as the experimental and analytical 
set-ups established in each laboratory. We have started to systematically 
study the human kinome interaction network in the cellular environment, by 
applying a systems level approach that is not only focused on the generation 
of an exhaustive functional annotation, but that primarily aims at the 
production of highly reliable data. The results obtained on a subset of 
purified complexes generated through this approach allow us to suggest 
new standards concerning data quality in mass spectrometry analysis, and 
constitute a first valuable fraction of the final kinome interaction map. 
 42 
COMBINATORIAL DEPLETION ANALYSIS TO ASSEMBLE THE 
NETWORK ARCHITECTURE OF THE SAGA AND ADA 
CHROMATIN REMODELING COMPLEXES 
 
Mihaela E Sardiu, Kenneth Lee, Laurence Florens, Jerry Workman, 
Michael P Washburn  
 
Stowers Institute for Medical Research, Proteomics, Kansas City, MO, 
64110 
 
At a higher level of structure, proteins within a cell interact dynamically 
with specific partners to form functional modules and consequently 
macromolecular assemblies which are responsible for particular processes 
in a cell. To date it remains a key challenge to discover and understand how 
proteins interact and are spatially arranged to form these macromolecular 
functional modules. The high-resolution characterization of multi-protein 
assemblies at physiological conditions is generally hard to achieve using 
traditional methods such as X-ray crystallography or NMR. However, even 
if it is not feasible to determine the structure of protein complexes at atomic 
or amino acid levels, methods predicting lower resolution macromolecular 
models explaining the position of proteins and their interrelationships 
within complexes still improve our understanding of these protein 
assemblies and the cellular processes they are involved in.  
As a starting point for predicting a lower resolution description of protein 
complexes we developed a method combining computational approaches 
and quantitative proteomics data generated from a systematic collection of 
wild-type and different deletion strain purifications. In order to test this 
approach we generated and analyzed a dataset aiming to gain novel insights 
intothe Saccharomyces cerevisiae SAGA (Spt-Ada-Gcn5) histone 
acetyltransferase (HAT) complex. Our unique method allowed us to refine 
the architectural organization of both complexes by separating its distinct 
functional modules, which allows to explain the shared and unique 
functions of either complex, and also helps to characterize functional 
consequences of perturbations to the system. The identification of the 
different modules is also a crucial step for defining the direct subunit-
subunits contacts within protein complexes. Furthermore, this approach also 
led to the identification of a novel integral subunit of the ADA complex, 
which we termed Ahc2, and to the characterization of Sgf29 as an ADA 
family protein which is present in all Gcn5 HAT complexes.  
Finally, we could demonstrate that this unique approach also allows the 
prediction of novel functional associations within the SAGA complex and 
provides mechanistical insights into phenotypical observations in SAGA 
mutants.  
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Motivation: Clarification of compounds’ mode of action is a common 
objective in scientific research both for academia and especially for the 
pharmaceutical industry. Elucidating the mode allows for detailed analyses 
of on as well as off target effects. It is mediated by binding of compounds to 
proteins subsequently influencing related regulatory networks within the 
organism. As more and more data from diverse sources is available, the 
integration of this knowledge is an important step to get a deeper insight 
into biology.  
Results: Here, we have integrated for the first time comprehensive 
information about the relatedness of proteins. In order to resolve mode of 
action, protein interactions are taken from iRefIndex and enriched with 
information about transcription factor binding sites, Gene Ontology 
annotation as well as gene expression measurements. Finally, the 
accumulated information is translated to edge weighted graphs and 
subnetworks are extracted based on protein interactions exhibiting high 
contextual relatedness. Results are quantitatively evaluated by a comparison 
to randomized networks. Finally the biological context of the identified 
protein interactions is elucidated by conducting Fisher’s exact test on gene 
sets as for example determined by Reactome.  
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It is important to determine cell-type-specific gene expressions in order to 
understand cellular mechanisms. Genes expressed only in the same multiple 
cell types may share common functional components. Particularly in higher 
species, these genes are associated with specific tissues, developmentally 
close cells, or histologically similar cells; furthermore, defects in their 
associated genes may engender diseases in several related tissues and may 
cause serious damage during developmental processes. 
 
To identify these biologically important genes, we developed a novel 
computational method that extracts functional gene networks associated 
with plural cell types by combining gene expressions with protein-protein 
interactions. We applied this method to human gene expressions observed 
in 79 tissues with large protein-protein interaction networks. We termed the 
extracted networks “tissue-sharing networks” (TSNs). Predicted TSNs 
reveal networks related to multiple tissues that are developmentally or 
histologically similar to one another, and the tissue-specific expressions of 
the TSN genes are conserved in mouse tissues. Many genes in TSNs are 
responsible for the occurrence of diseases in more than 1 tissue. However, 
the genes in TSNs do not overlap greatly with essential genes. Our results 
confirm that our method is a potential tool for the discovery of genes 
involved in developmental biology, pathology, and genetics. 
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Elucidating the differences between cellular responses to various biological 
conditions or external stimuli is an important challenge in systems biology. 
Many approaches have been developed to reverse engineer a cellular 
system, called gene network, from time series microarray data in order to 
understand a transcriptomic response under a condition of interest. 
Comparative topological analysis has also been applied based on the gene 
networks inferred independently from each of the multiple time series 
datasets under varying conditions to find critical differences between these 
networks. However, these comparisons often lead to misleading results, 
because each network contains considerable noise due to the limited length 
of the time series. We propose an integrated approach for inferring multiple 
gene networks from time series expression data under multiple biological 
conditions and present a new parameter estimation method, relevance-
weighted recursive elastic net, for providing higher precision and recall than 
existing reverse-engineering methods. We analyze experimental data of 
MCF-7 human breast cancer cells stimulated by epidermal growth factor or 
heregulin with several doses and provide novel biological hypotheses 
through network comparison. 
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Mitochondria are a vital component of eukaryotic cells, with functions that 
extend beyond energy production to include metabolism, signalling, cell 
growth and apoptosis. Their dysfunction is implicated in a large number of 
metabolic, degenerative and age-related human diseases. Therefore, it is 
important to gain an understanding of mitochondrial metabolism as this 
may provide an insight into these disorders. To this end a new manually 
curated metabolic model of the mitochondrion was created. The framework 
for its construction was MitoMiner, a new mitochondrial proteome 
database. The model was built by evaluating the localisation of 2187 
reactions that had either experimental evidence for mitochondrial 
localisation or were annotated as mitochondrial, using the principle of 
metabolite availability. The resultant model contains 242 reactions and is 
the most comprehensive of its type available to date. Flux balance analysis 
was used to simulate metabolism and showed the fluxes representing core 
metabolism compared well with experimentally measured figures, 
suggesting the model is biologically relevant. The model was then used to 
simulate several metabolic disorders including fumarase deficiency and 
pyruvate dehydrogenase deficiency. The results of these simulations 
corresponded well with phenotypic data from the primary literature and 
provided some insight into the complicated and unintuitive phenotypes of 
these disorders, allowing several predictions to be made. 
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Alzheimer’s disease (AD) is a devastating neurodegenerative disorder 
characterized neuropathologically by the extracellular accumulation of 
amyloid-β (Aβ) plaques and the intracellular accumulation of 
hyperphosphorylated Tau protein in the form of neurofibrillary tangles 
(NFTs). Although highly heritable, AD is associated with multiple genetic 
defects either mutational or of susceptibility, making genetic analysis 
difficult. This is particularly relevant for the sporadic late-onset AD, which 
accounts for more than 90% of AD cases. 
 
In order to uncover novel genetic risk factors whose susceptibility 
implication in AD still remains unclear, we have applied an integrative 
approach between network modelling and an AD disease-oriented focus to 
generate a stringent protein interaction network for AD causative and 
susceptibility genes. 
 
Our phenotype-based network revealed four novel interactions among 
known AD causing genes and, notably, identified 170 novel interactions 
with AD related genes. Bioinformatics analysis showed functional 
categories among AD susceptibility genes to common cellular pathways 
like inflammation and oxidative stress that might lead to mitochondrial 
dysfunction and ultimately to neuronal death. Finally, this protein 
interaction network provides 50 candidate genes for AD whose genetic 
defect has not yet been identified.  
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BISTABLE RLR-IFNβ SIGNALING SYSTEM DETERMINES 
APOPTOTIC CELL FATE 
 
Sun-Young Hwang1, Kye-Yeon Hur2, Seung-Hwan Kim2,3, Jeong-Rae 
Kim4, Kwang-Hyun Cho4, Joo-Yeon Yoo1,2  
 
1POSTECH, Life Science, Pohang, 790-784, South Korea, 2POSTECH, 
2School of Interdisciplinary Bioscience and Bioengineering , Pohang, 790-
784, South Korea, 3POSTECH, Physics, Pohang, 790-784, South Korea, 4 
KAIST, Bio and Brain Engineering, Daejeon, 305-701, South Korea 
 
IFNs play key roles in the fate decisions of virus-infected cells. Cytosolic 
RLRs sense foreign RNA and activate signaling cascade to produce IFNβ, 
which modulates its own synthesis through multiple feedback loops. Using 
mathematical modeling and biochemical experimentation, we have 
characterized the RLR-IFNβ production signaling system. The cooperative 
production of RLR and the intrinsic synthesis rates of RLR are analyzed as 
the primary factors influencing the bistability of the system. Using IFNβp-
GFP-IFNβUTR reporter cells transfected with Cy5-polyI:C, characteristics 
of biphasic IFNβ production have been analyzed in the mammalian cellular 
system. Our findings suggest that the RLR-IFNβ production system is 
intrinsically bistable, mainly due to genetically wired regulatory circuits and 
cellular feedback regulation, which determine the dynamics of IFNβ 
production and the fate of virus-infected cells. 
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High-throughput interaction discovery initiatives are providing thousands of 
novel protein interactions which are unveiling many unexpected links 
between apparently unrelated biological processes. In particular, analyses of 
the first draft human interactomes highlight a strong association between 
protein network connectivity and disease. Indeed, recent exciting studies 
have exploited the information contained within protein networks to 
disclose some of the molecular mechanisms underlying complex 
pathological processes. These findings suggest that both protein-protein 
interactions and the networks themselves could emerge as a new class of 
targetable entities, boosting the quest for novel therapeutic strategies. In this 
talk, I will summarize our work towards the characterization and modelling 
of the protein-interaction network underlying Alzheimer´s disease, together 
with our most recent attempts to decipher complex cell networks to the 
point of being able to predict how the perturbation of a node might affect 
the system as a whole. 
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I will present a discussion of the genetic basis for different subtypes of 
breast cancer. Using transcriptome and exome sequencing we have 
identified novel isoforms predictive of breast cancer progression, and we 
have determined genetic markers predictive of triple negative (basal type) 
vs. Estrogen Receptor positive breast cancers. These results are very 
promising for early identification and treatment of breast cancers that differ 
in their prognosis, but also suggest that exome sequencing may generally be 
a very powerful tool for dissecting the genetic basis of complex diseases. 
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It is well known that all cancers accumulate somatic mutations, and these 
mutated genes, called cancer genes, are the cause of cancer. There has been 
a lot of efforts to identify these cancer genes that are causative of cancer 
when mutated, and high-throughput sequencing technologies accelerate 
these studies by finding out the somatic mutations in tumour samples at 
genomic level. However, not all somatic mutations in cancer genome are 
involved in oncogenesis. Some of the mutations known as 'driver mutations 
' confer growth advantages to the cells while the other mutations called 
'passenger mutations' do not contribute cancer development. Therefore, 
distinguishing the genes which carry the driver mutations from the genes 
that have passenger mutation is very important to understand oncogenesis. 
Here we made a network-based classifier, to distinguish cancer genes from 
passenger-mutated genes by scoring somatically mutated genes in cancer 
genomes. The idea is that the highly ranked genes that have high scores by 
the classifier are more likely to have driver mutation and ,therefore, 
regarded as cancer genes. On the other hand, low-scored genes are not 
regarded as cancer genes, and the mutation they have are expected to be a 
passenger mutation. We made a 4 kinds of Network-based classifiers by 
using Human Network and Worm(C.elegans) Network : Degree centrality, 
GBA(Guilt by association), geneMANIA algorithm, and integrated version 
of these 3 classifier. Also, we collect 2972 somatically mutated genes from 
unbiased sequencing data of breast, colorectal, and pancreatic cancer and 
glioblastoma multiforme(GBM), and made a candidate cancer gene list. We 
evaluated those classifier by training set(384 cancer genes) from Cancer 
Gene Census by Welcome Trust Sanger Institute. We then map those 
candidate genes to C.elegans for further biological validation. 
The networks that we used are functional networks, which include many 
kinds of information such as PPI, co-expression, and many other 
information. Therefore, we expect that the classifier based on the these 
functional networks are reliable, and suggest new approach to distinguish 
driver mutations from passenger mutations. 
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The use of high throughput technology in molecular biology is rapidly 
increasing the amount and the number of different types of ‘omics’ data. 
The fast accumulation of diversified biological information generates 
fragmented, and sometimes contradictory, scenery which emerges from 
cross-comparison of data from different sources (publications and 
databases). Therefore, systematic assembling, organization and integration 
of this information is an urgent need in computational biology and will 
allow complementation of different pieces of evidence based on a holistic-
network-driven approach. The single-gene-biomarker paradigm is now 
replaced by a network-based approach to biomarker discovery and disease 
prediction, which merges the omics perspective at different levels: from 
single-nucleotide polymorphism (SNP) (1) to regulatory networks (2). 
We tested applicability and robustness of the systems biology approach, in 
search for relevant subnetwok modules and pathway-based biomarkers for 
diverse group of phenotypic traits and diseases including: mammary 
gland/milk traits, mastitis, fat deposition, male reproduction, cryptorchidism 
and chronic lymphocytic leukemia. The following procedure was employed: 
1) extracting diverse omics data from the literature and databases, 
2) data organization, identification and visualization of overlapping genetic 
loci,  
3) systems biology analysis including visualization of relevant microRNA-
mRNA interactions, protein-protein interactions and pathways, 
4) development of network/pathway based biomarkers, 
5) experimental confirmation. 
We are refining a robust protocol for pathway based biomarker 
development which could be used for other fields of research. 
 
1. Hannum G, Srivas R, Guenole A, van Attikum H, Krogan NJ, Karp RM, Ideker 
T. Genome-wide association data reveal a global map of genetic interactions among 
protein complexes. PLoS Genetics 2009;5:e1000782. 
 
2. Ravasi T, Cannistraci CV, Katayama S, Bajic VB, Tan K, Akalin A, Schmeier S, 
et al. An atlas of combinatorial transcriptional regulation in mouse and man. Cell 
2010;140:744-752. 
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Physiology relies on the concerted action of a number of molecular 
interactions of gene products and metabolites operationally organized in so-
called pathways and in yet larger molecular networks. Through integrated 
approaches using proteomics as central “glue” it is possible to obtain 
physical, functional and “knowledge” maps of human pathways. We use 
affinity proteomics using TAP-mass spectrometry to chart protein 
complexes and larger molecular networks and use drugs to establish target 
profiles. The combination of these approaches allows not only to map 
drug/ligand- target relationships but also to position these elements onto 
molecular pathways. We mapped pathways involved in innate immunity 
and in chronic myelogenous leukemia. We also compared five drugs against 
CML and investigated the Bcr-Abl protein network. The data suggest: 1. It 
is possible to map entire human signaling pathways using mass 
spectrometry-based proteomics, 2. Even “modern” targeted drugs are 
promiscuous, 3. Drug targets may generally be part of larger protein 
complexes, 4. Binding partners of targets may influence drug action on the 
complex and in turn be affected by it, 5. In light of cellular “proteostasis”, 
complex components may become available after drug treatment and 
redistribute to affect other signaling pathways, 6. Drugs are likely to be 
understood as systems perturbers and not “erasers” of protein activity (with 
some gain-of-function effects matching loss-of-function). A better 
understanding of these perturbations should form the basis for an informed 
combination-type of therapy. 
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Schizophrenia is a mental disorder with a significant impact on both the 
personal and societal level. It is highly heritable, and approximately 1% of 
the population manifests the disease. In spite of its prevalence and strong 
genetic component, the etiology of schizophrenia remains elusive because 
of its nature as a complex trait. In this work, we used a variety of data 
sources and novel computational techniques to investigate whether 
disparate risk factors and associated genes are connected by a common 
molecular mechanism. As a first step in this analysis, we integrated gene 
expression data sets derived from brain tissue of several cohorts and used 
Random Forests to classify subjects as schizophrenic or control, based on 
gene expression. We used the variable importance measures resulting from 
this classification procedure to learn which combinations of genes were 
crucial for distinguishing schizophrenia patients and controls. These 
importance measures were combined with text mining evidence to build a 
set of high-confidence schizophrenia-associated genes. To further explore 
the regulatory context of these genes, we exploited systems genetics data 
from a recombinant inbred panel of mice that vary widely in their 
neurological phenotypes. Specifically, we examined three types of 
regulatory relationships to give context to these risk genes: upstream 
regulators, downstream targets, and lateral (epistatic) co-regulators. 
Examining these complex relationships was made possible by a novel 
extension of Random Forests that utilizes latent information in the forest 
structure. The insight gained through this work demonstrates the value of a 
systems approach when deconstructing the etiology of schizophrenia, and 
the presented framework also has wider applicability to complex diseases in 
general. 
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Estrogen is known to induce growth in estrogen receptor (ER)-positive 
breast cancer cells. Paradoxically, in breast cancer cells that have been 
chronically deprived of estrogen stimulation, re-introduction of the hormone 
can induce apoptosis. Here, we sought to identify signaling networks that 
are triggered by estradiol (E2) in isogenic MCF-7 breast cancer cells that 
undergo apoptosis (MCF-7:5C) versus cells that proliferate upon exposure 
to E2 (MCF-7). One focus was on proteins interacting with the nuclear 
receptor co-activator AIB1 (Amplified in Breast Cancer-1) the other on 
complexes containg tyrosine phosphorylated proteins. AIB1 is known to be 
rate-limiting for E2-induced cell survival responses in MCF-7 cells and was 
found here to also be required for the induction of apoptosis by E2 in the 
isogenic MCF-7:5C cells. Proteins that interact with AIB1 as well as 
complexes that contain tyrosine phosphorylated proteins were isolated by 
immunoprecipitation and identified by mass spectrometry (MS) at baseline 
and after a two hour exposure to E2. Bioinformatic network analyses of the 
identified protein interactions were then used to analyze E2 signaling 
pathways that trigger apoptosis versus survival. Comparison of MS data 
with a computationally-predicted AIB1 interaction network showed that 22 
proteins identified in this study are within this network, and are involved in 
signal transduction, transcription, cell cycle regulation and protein 
degradation. G-protein-coupled receptors, PI3 kinase, Wnt and Notch 
signaling pathways were most strongly associated with E2-induced 
proliferation or apoptosis and are integrated here into a global AIB1 
signaling network that controls qualitatively distinct responses to estrogen. 
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Germline polymorphisms influence gene expression networks in normal 
mammalian tissues. Common genetic variants have also been shown to 
affect many complex traits including cancer susceptibility. However, factors 
responsible for most of the expected heritable risk of cancer development 
have not yet been identified. Finding these alleles and isolating the causal 
polymorphisms is challenging because the heritable component of 
susceptibility is influenced by many alleles exerting modest effects which 
may be pleiotropic, epistatic, or context-dependent. We have previously 
identified alleles affecting the expression of networks of genes which 
influence complex traits including inflammation and cancer susceptibility. 
Analysis of the genetic architecture of gene expression in normal skin from 
a Mus spretus / Mus musculus backcross identified expression Quantitative 
Trait Loci (eQTL) that influence both structural and functional phenotypes 
including hair follicle development, inflammation and tumor susceptibility. 
Changes in germline influence on gene expression during the development 
of benign and malignant tumors have not been investigated systemically. 
We now document major changes in germline control of gene expression 
during skin tumor development, likely reflecting cell selection, somatic 
genetic events, and changes in tumor microenvironment. Numerous genes, 
including the immune response genes Interleukin 18 and Granzyme E, are 
under germline control in malignant tumors but not normal skin. Gene 
expression networks linked to tumor susceptibility and hair follicle stem 
cell markers in normal skin undergo significant reorganization during tumor 
progression. Our data highlight opposing roles of Interleukin-1 signaling 
networks in tumor susceptibility and tumor progression and have 
implications for the development of chemopreventive strategies to reduce 
cancer incidence. 
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Gene regulatory networks (GRNs) provide insights into the mechanisms of 
differential gene expression at a systems level. GRNs that relate to 
metazoan development have been studied extensively. However, little is 
still known about the design principles, organization and functionality of 
GRNs that control physiological processes such as metabolism, homeostasis 
and responses to environmental cues. I will present the first experimentally 
mapped metazoan GRN of Caenorhabditis elegans metabolic genes. This 
network is enriched for nuclear hormone receptors (NHRs). The NHR 
family has greatly expanded in nematodes: humans have 48 NHRs, but C. 
elegans has 284, most of which are uncharacterized. We find that the C. 
elegans metabolic GRN is highly modular and that two GRN modules 
predominantly consist of NHRs. 
Network modularity has been proposed to facilitate a rapid response to 
different cues. As NHRs are metabolic sensors that are poised to respond to 
ligands, this suggests that C. elegans GRNs evolved to enable rapid and 
adaptive responses to different cues by a concurrence of NHR family 
expansion and modular GRN wiring. 
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The Arabidopsis Thaliana flower consists of four types of organs, that grow 
in four concentric whorls on the floral meristem. In each whorl, the identity 
of the cells is determined by the concentrations of five types of MADS 
proteins.  
In this presentation we investigate the sensitivity and robustness of a model 
describing the dynamics of the gene regulatory network that is responsible 
for flower organ identity [1]. This recently developed model incorporates 
transcription regulation via Michaelis-Menten kinetics, decay, dimer 
interactions. It also includes so-called trigger mechanisms, short boosts of 
protein production, that turn out to ultimately lead to four types of cell 
differentiation. This model generates realistic gene expression patterns in 
the different whorls, and has been validated by successful predictions of 
mutant phenotypes.  
In this model no cell-cell interactions are yet included, such as protein 
transport between cells. In [2] is was shown that the MADS proteins can 
easily travel through cell membranes, giving rise to a large diffusive effect. 
This diffusion was not yet included in the model in [1]. This raises the 
question how robust this model is against inclusion of diffusive effects. For 
example, how are the four steady states of the model, each corresponding to 
one of the whorls, affected by an extension of the model with diffusion. In 
this talk the biological and mathematical implications of this question will 
be treated.  
 
[1] Continuous-time modeling of cell fate determination in Arabidopsis 
flowers. Simon van Mourik, Aalt-Jan van Dijk, Maarten de Gee, Richard 
Immink, Kerstin Kaufmann, Gerco Angenent, Roeland van Ham, and Jaap 
Molenaar. Submitted to BMC Systems Biology, 2010.  
[2] Intercellular transport of epidermis-expressed MADS domain 
transcription factors and their effect on plant morphology and floral 
transition. Susan L. Urbanus, Adriana P. Martinelli, Q.D. (Peter) Dinh, 
Lilian C.B. Aizza, Marcelo, C. Dornelas, Gerco C. Angenent, and Richard 
G.H. Immink. Accepted by Plant Journal, 2010. 
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When is a biological network functionally typical or atypical, pathological 
or healthy? To answer this we may need to ask: how should we compare 
biological networks? Our means of comparison should indicate when 
networks with similar functions are indeed similar. Unfortunately, a good 
understanding of network function requires knowledge of the processes on 
the network, but this is something we often lack. Some good news is that 
despite this problem, some structural features of networks, the modular or 
community structure of the network, can put a strong constraint on many 
plausible types of network dynamics. As a result there might indeed be a 
connection between network structure and system function. 
 
We create a characteristic signature of the modular structure of networks by 
probing them at multiple resolutions. We use this signature to cluster a set 
of networks from across the sciences and find that we group networks of 
similar functions together. This allows us to consider a taxonomy of 
networks. We also consider a case study of a comparison of the structure of 
a large set of fungal networks and also find structural similarities between 
some protein interaction data and networks of scientific collaborations. 
 
This method can be used to detect anomalous networks and identify 
connections between apparently disparate types of systems. 
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Background 
Molecular crowding and proteome diversity permanently require cells to 
adjust the quantities of the proteins they produce. Arguably, protein 
abundance must be balanced in an complex manner to enhance functional 
protein-protein interactions (PPI) while limiting non-specific associations. 
Despite this constraint, cells have strikingly evolved more than six orders of 
magnitude in the binding affinities of their PPI, from transient to stable 
interactions. How is this possible? Addressing this problem requires to 
understand how a cell regulates the flux of synthesis and degradation of 
proteins involved either in transient or stable interactions. We hypothesized 
that distinct strategies exist to regulate stable or transient proteins 
interactions. 
 
Results 
We integrated multiple large scale datasets describing most of the 
regulatory steps influencing protein abundance, and used statistical network 
analysis to investigate the interplay between regulatory properties and 
topologies in 3 S.cerevisiae PPI networks. We present evidence for distinct 
constraints in the regulation of stable and transient PPI, in the form of 
significantly more/less enhanced use of a particular regulatory step during 
protein synthesis. In particular, distinct constraints are found at the 
transcriptional, post-transcriptional and post-translational levels, as well as 
for protein noise (single-cell variations of protein abundance). 
 
Conclusion 
We provide a comprehensive analysis of protein abundance regulation in 
three distinct protein interaction networks. We show that stable and 
transient PPI are under distinct patterns of regulation. This likely provides 
several degrees of freedom for the cell to dynamically fine-tune abundance 
of proteins involved in stable or transient interactions. Our findings have 
implications for a system-level understanding of the dynamics of protein 
interactions and for synthetic biology experiments aimed at engineering 
functional interactions. 
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In several organisms from prokaryotes to yeast and fly, modifications in the 
dosage of essential genes, genes coding for protein complexes, and network 
hubs are deleterious and often lethal. This has been interpreted as a sign of 
fragility of these genes towards perturbations, because dosage modifications 
of essential and highly connected proteins may cause the simultaneous 
disruption of tightly regulated biological processes. Recently, our and other 
labs have shown that mammalian networks behave differently from other 
species. In mouse and human, the majority of genes coding for hubs have 
paralogs and essentiality is not always anticorrelated to duplicability. In this 
context, genes that are somatically modified in cancer (i.e. cancer genes) 
constitute an exception: they are mostly singletons but they encode proteins 
that are highly connected. This finding suggests that cancer genes constitute 
a point of fragility in the human interactome and that they have evolved 
differently from other singleton genes, gaining peculiar genetic and network 
properties.  
Here we present the newest results of a study that aimed at clarifying when 
the differences between the interaction networks of mammals and other 
species arose during evolution and how they affected the evolution of 
cancer genes. We specifically focused on four species (human, fly, yeast, 
and E.coli) that represent major transitions towards the progressive increase 
in complexity during evolution and for which good quality genomic and 
primary interaction data are available. In all these species we compared 
network properties of each node with conservation and duplicability of the 
corresponding gene. We discovered that in all species, including human, 
very ancient and conserved genes encode singleton and central hubs. These 
genes usually accomplish very basic functions that deal with the survival of 
the cell. A second group of hubs can be found only in human because they 
appeared later in evolution and duplicated through the two rounds of 
vertebrate-specific whole genome duplication. These recent hubs are 
involved in more complex functions, such as signaling, cell-to-cell 
communications, and regulation of biological processes. We also 
discovered that the dosage of these genes is regulated through alternative 
and more sophisticated mechanisms. Interestingly, cancer proteins are 
mostly ancient and they therefore result enriched in singleton hubs.  
 62 
IMMUNE SIGNALING LANDSCAPE: INTERROGATING SINGLE 
CELLS IN 30 DIMENSIONS 
 
Rachel Melamed1,2, Elad David-Amir1,2, Sean C Bendall3, Erin Simonds3, 
Karen Sachs3, Garry Nolan3, Dana Pe'er1,2  
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2Columbia University, C2B2, New York, NY, 10032, 3Stanford University, 
Department of Microbiology and Immunology, Palo Alto, CA, 94305 
 
We employ mass cytometry, a recently developed technology, to measure 
the abundance of over thirty surface and signaling proteins at single cells 
resolution in complete bone marrow samples. High dimensional clustering 
was used to identify immune cell types. Clustering finds many of the known 
cell types, but also finds a more complex landscape of cell types than 
previously appreciated. We mapped signaling events onto this immune 
landscape gaining a comparative and comprehensive view signaling 
networks in the immune system. 
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RESPONSE TO DNA DAMAGE 
 
Sourav Bandyopadhyay1, Monika Mehta2, Ruedi Aebersold3, Michael-
Christopher Keogh2, Nevan J Krogan4, Trey Ideker1  
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Genetic networks are central to pathway structure and function but the 
effects of different environmental conditions on these networks and the 
pathways they represent are poorly understood on a global scale. We report 
the generation of genetic interaction networks among all yeast signaling and 
transcriptional machinery before and after exposure to DNA damage. This 
perturbation induces a distinct genetic network that is greater in size than 
the untreated network and whose interactions are largely DNA-damage 
specific. In addition, the inducible network has guided the discovery of new 
DNA damage response pathways involving the phosphatase Pph3 and 
histone variant Htz1. Thus, inducible genetic networks are a valuable tool 
for mapping pathways stimulated by specific conditions and probing an 
uncharted space of the genetic interactome. 
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PEPTIDE-MEDIATED INTERACTIONS IN HIGH-RESOLUTION 3D 
STRUCTURES 
 
Amelie Stein1,2, Patrick Aloy1,2,3  
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Many biological responses to intra- and extracellular stimuli are regulated 
through complex networks of transient protein interactions where a globular 
domain in one protein recognizes a linear peptide from another, creating a 
relatively small contact interface. These peptide stretches are often found in 
unstructured regions of proteins, and contain a consensus motif 
complementary to the interaction surface displayed by their binding 
partners. While most current methods for the de novo discovery of such 
motifs exploit their tendency to occur in disordered regions, our work here 
focuses on another observation: upon binding to their partner domain, 
motifs adopt a well-defined structure. Indeed, through the analysis of all 
peptide-mediated interactions of known high-resolution three-dimensional 
(3D) structure, we found that the structure of the peptide may be as 
characteristic as the consensus motif, and help identify target peptides even 
though they do not match the established patterns. Our analyses of the 
structural features of known motifs reveal that they tend to have a particular 
stretched and elongated structure, unlike most other peptides of the same 
length. Accordingly, we have implemented a strategy based on a Support 
Vector Machine that uses this features, along with other structure-encoded 
information about binding interfaces, to search the set of protein 
interactions of known 3D structure and to identify unnoticed peptide-
mediated interactions among them. We have also derived consensus 
patterns for these interactions, whenever enough information was available, 
and compared our results with established linear motif patterns and their 
binding domains. Finally, to cross-validate our identification strategy, we 
scanned interactome networks from four model organisms with our newly 
derived patterns to see if any of them occurred more often than expected. 
Indeed, we found significant over-representations for 64 domain-motif 
interactions, 46 of which had not been described before, involving over 
6,000 interactions in total for which we could suggest the molecular details 
determining the binding. 
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Protein interaction networks (PINs or interactomes), protein signaling 
networks (PSNs) and gene regulatory networks have successfully been used 
to classify drug-target interactions, identify master transcriptional regulators 
and uncover new disease genes. Unfortunately, PINs and PSNs are rarely 
cell-type specific and do not encode the input-output relationships required 
for analyzing receptor-mediated signaling cascades and the drugs that target 
them. Conversely, traditional approaches to studying cell signaling do not 
make use of the wealth of information that is now encoded in PINs and 
PSNs. Here we describe a hybrid method to convert PSNs into logical 
models (either discrete Boolean models or quantitative Fuzzy-logic models) 
that can be trained against data in which cells are exposed to-combinations 
of ligands and drugs followed by multiplex biochemical measurement of 
intracellular responses, and its implementation it in the toolboxes 
CellNetOptimizer (Mol. Sys. Biol., 5:331, 2009) and DataRail 
(Bioinformatics, 15(24):840, 2008). Our approach can accommodate 
network information from different sources (manual curation, text mining, 
and high-throughput experiments). We apply the method to distinguishing 
the topologies of immediate early signaling networks in primary human 
hepatocytes and four hepatocellular carcinoma (HCC) cell lines. We show 
that five distinct models cluster topologically into normal and diseased sets, 
revealing functional differences between normal and diseased cells that 
involve activation of growth factor receptors and intracellular kinase 
cascades. In a proof-of-principle experiment we also infer a target for an I-
kappa B kinase inhibitor developed to treat arthritis and airway 
inflammation. 
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My group studies the development of mouse limb buds as a paradigm for 
vertebrate organogenesis. In particular, we are interested in identifying and 
understanding the signalling systems that control the coordinate 
proliferative expansion and specification of the mesenchymal progenitors 
destined to form the chondrogenic elements of the future limb skeleton. We 
have recently uncovered a robust, but highly dynamic system of interlinked 
signalling feedback loops that controls progression of limb bud 
development in a largely self-regulatory manner. The challenge is now to 
integrate both spatial and temporal information into our mathematical 
simulations starting from quantitative and functional genetic data. To this 
aim we are developing novel genetic tools that aid our in vivo quantitative 
analysis of the molecular systems that control initiation and progression of 
mouse limb bud development. We have already identified several signalling 
modules that are molecularly interlinked such that limb bud axes 
development is temporally and spatially coordinated. I will present our 
ongoing functional analysis of the dynamic functions of two main 
gatekeepers in the BMP and SHH signalling pathways, the Smad4 and Gli3 
transcriptional regulators. Finally , I will discuss the importance of 
combining genetic and quantitative analysis with data-driven mathematical 
simulations to achieve a comprehensive understanding of the complex 
morpho-regulatory interactions (in collaboration with Prof. D. Iber and Dr. 
A. Zuniga). 
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Really Interesting New Genes (RINGs) comprise over half of the predicted 
E3 ligases encoded within the human genome. As such they play a large 
part in controlling the specificity and functionality within the ubiquitin 
system. Whilst catalytically inert, they act as molecular scaffolds which 
bring specific E2 conjugating enzymes and substrate into close proximity to 
allow ubiquitination to occur. However, RING proteins have also been 
shown to homo- and hetero- dimerise, with some family members forming 
higher order multimeric complexes. Several studies have investigated the 
functional implications of selective oligomerisation events however the full 
extent or importance of RING-RING interactions has not been 
systematically studied.  
In this study two differing vectors systems were utilised in high throughput 
yeast-two-hybrid screens to investigate binary protein-protein interactions 
of a subset of the human RING proteins. In both screens against E2 
conjugating enzymes and E3 RING proteins different vector systems 
provided complimentary datasets which increase coverage of binary 
interactions within the ubiquitin network. 
Site directed mutagenesis and in vitro ubiquitination assays were used to 
verify E2/E3-RING interactions, while co-expression and co-precipitation 
studies were performed to investigate putative 3-RING/E3-RING 
interactions and provided new insights into the extent, specificity and 
functional consequences of E3-RING oligomerisation networks. 
Interactions between 125 soluble E3-RING proteins were tested revealing 
228 high confidence binary interactions. Of the interactions re-tested in 
secondary assays > 71% of positive and 100% of negative interactions were 
reconfirmed indicating a high degree of confidence in the Y2H derived 
network. 
Data from these studies were combined with known interaction data to 
generate a human E3 RING network containing 4345 binary interactions. 
The canonical E1/E2/E3-RING enzymatic cascade has been investigated 
heavily and the combinatorial complexity of E2/E3-RING interactions 
within this system has been reported. However, the frequency and 
consequences of E3-RING oligomerisation remain less well documented. 
Here we present a network of binary E3-RING/E3-RING interactions 
within the context of the human ubiquitome. This data suggests that E3-
RING/E3-RING interactions may confer a further level of fidelity within 
the ubiquitination cascade. In particular, E3-RING binding preferences may 
control the specificity and architecture of substrate ubiquitination through 
the selective recruitment of different E2-conjugating enzymes. 
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Exposure of cells to DNA-damaging agents activates signal transduction 
cascades that affect DNA repair, cell cycle progression, and cell survival. 
Different cellular strategies exist to cope with DNA damage: damage is 
tolerated (with the risk that cells acquire malignant properties), damage is 
repaired, or cells with damaged DNA are removed from the tissue. The 
latter strategy involves a complex of signal transduction pathways that can 
induce various types of cell death, including apoptosis. In a highly 
simplified model DNA-damage causes activation of the sensor kinases 
(ATM, ATR, DNA-PK) that activate p53 and the checkpoint kinases (Chk1, 
Chk2), which in turn regulate effector pathways that control repair, cell 
cycle and cell survival. In reality, the process is much more complex with 
many additional regulators, extensive cross-talk, and multiple positive and 
negative feedback loops. Posttranslational modifications play a crucial role 
in the transmission of the signal during the DNA-damage response. In this 
project, we make use of gene family short interference (si)RNA libraries to 
identify kinases and phosphatases that are involved in the apoptotic 
response to various DNA-damaging drugs in ES cells. High throughput 
screening for cell viability has identified potential regulators of the 
sensitivity of ES cells to the DNA damaging drug Cisplatin. In addition, 
automated high content live cell imaging analysis is used to qualitatively 
and quantitatively follow the onset of apoptotic cell death, providing kinetic 
information of the process. From ~900 genes screened, 86 have been 
identified as potential hits, and have entered the validation process. In 
parallel, phosphoproteomics (SILAC) data have been obtained for exposure 
of ES cells to Cisplatin. Bioinformatics analysis of these two datasets is 
used to link our hits to posttranscriptional modifications of their substrates. 
We aim to build functional signaling networks involved in the response to 
Cisplatin-induced DNA damage in ES cells. These will be tested for 
multiple compounds and cell types, including cancer cells. In summary, this 
strategy will allow us to define potential biomarkers and new drugable 
targets in order to improve chemotherapeutic treatments. 
 
*Supported by the Netherlands Toxicogenomics Center. 
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Protein phosphorylation is one of the most well characterized post-
translational modifications. Yet, very little is known about the evolutionary 
dynamics of kinase-substrate interactions and its functional consequences. 
We have used a mass-spectrometry approach to characterize the in-vivo 
phosphoproteomes of three fungal species (S. cerevisiae, S. pombe, C. 
albicans) and have combined this data with cross-species genetic interaction 
data for comparative studies. We observed that kinase-substrate interactions 
change at a fast rate although the average level of phosphorylation of 
functional groups (i.e. complexes, signaling pathways) is well conserved. In 
order to address this apparent contradiction we have developed methods to 
predict the function of known phosphorylation sites using structural 
information as well as data on other post-translational modifications. This 
analysis indicates that the positional conservation of phosphorylation sites 
significantly under-predicts the conservation of function. The observation 
that phosphorylation sites can change during evolution without affecting the 
function suggest that neutral evolution plays a significant role in shaping 
kinase-substrate networks. 
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A diverse set of biological functions in a diverse set of cells and organisms 
are performed by a myriad of biochemical networks. A major challenge in 
systems biology is to seek design principles or general rules that link 
network function and topology. I will present two case studies in which the 
network function limits the choice of the network topology to a very small 
set. One case concerns with the biochemical adaptation. We show that there 
are only two core topologies that can achieve perfect adaptation. The other 
case is the parasegments boundary formation in fruit fly development. The 
network topology for this patterning function has to be one of the few 
variants of a core topology. A function-topology map would help us 
comprehend natural biochemical networks, identifying key or missing 
nodes in the network and suggesting the network's function. It can also 
provide us with a manual to synthesize artificial networks. 
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METABOLIC NETWORK OF T. MARITMA. 
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Sequencing of a genome provides a foundation for the reconstruction and 
modeling of cell- and organism-level networks, which allow us to 
understand and eventually simulate entire cells and organisms. Knowledge 
of three-dimensional structures of proteins that compose such networks 
extends our understanding of the underlying processes to the atomic level. 
We developed a reconstruction of a central metabolic network for a 
hyperthermophilic bacterium, Thermotoga maritima, and followed it with 
experimental and computational determination of three dimensional 
structures of all proteins in the reconstruction. Combination of these two 
perspectives gave us the ability to analyze the network in novel ways. 
However, our reconstruction covered only the central metabolism i.e. less 
than 25% of the entire genome. Now, we attempt to extend the 
reconstruction to the entire T. maritima genome and in particular to include 
enzymes and probable enzymes that are specific to T. maritima. 
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Background: Understanding how information is encoded and transferred by 
biochemical networks is of fundamental importance in cellular biology. 
This requires analysis of the relationships between the stochastic trajectories 
of the constituent molecular species of the network. We will discuss how to 
identify conditional independences between the trajectories or time courses 
of groups of species. These are robust network properties that provide 
important insight into how information is processed.  
 
Objectives: The problem of how to decompose an entire network exactly 
into modules on informational grounds is considered: all information 
relevant to a particular module's trajectory should be encoded by those 
species in the region where the module overlaps with the rest of the 
network. In the context of signalling networks, the aim is to identify the 
route and species involved in sequential information processing between 
input and output modules.  
 
Methods: The MIDIA algorithm is presented which allows automated 
identification of exact decompositions for large networks and visualisation 
using a tree structure that encodes the conditional independences. The 
algorithm relies on construction of the Kinetic Independence Graph for the 
network and uses only stoichiometric information. No knowledge of rate 
parameters or use of simulation is required.  
 
Results: A bespoke version of the algorithm designed for signalling 
networks identifies the process of sequential encoding and visualises its 
structure using the collection of input-output paths in the tree. Together 
with the input-output path matrix introduced, this provides the first 
powerful, visual tool of its kind for investigating information processing by 
signalling networks. Application of the techniques to the Toll-like Receptor 
signalling network reveals that inputs can be informative for signalling 
outputs in ways unanticipated by steady-state analyses, that the information 
processing structure is not well described as a bow-tie, and that encoding 
for the interferon response is unusually sparse compared to other outputs of 
this innate immune system.  
 
Conclusion: The dynamic conditional independence-based techniques 
introduced require only stoichiometric information but have the strength of 
fully incorporating both stochastic and non-steady state dynamics. We 
believe they constitute an important step in the development of a 
quantitative theory of cellular information processing. 
 73 
DEAF PLANTS, BLEEDING YEAST, AND OTHER SURPRISING 
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Systems biology has shown great promise in providing a better 
understanding of human disease, and in identifying new disease targets. 
Nonetheless, it remains extraordinarily difficult to identify causal genes in 
most genetic diseases, in particular highly polygenic disorders, such as, for 
example, coronary artery disease, diabetes, and autism, for which current 
approaches are most limited. I’ll discuss recent progress on this problem, 
including an unusual approach for identifying candidate genes for polygenic 
diseases, based on mapping mutational phenotypes between organisms as 
distant as humans and plants or yeast, revealing new models of disease and 
candidate disease genes (the “phenolog” hypothesis). This method suggests 
a yeast model for angiogenesis defects, worm models for breast cancer and 
neural tube birth defects, and a plant model for the neural crest defects 
associated with Waardenburg syndrome, among others, and reveals 
functionally coherent, evolutionarily conserved gene networks—many 
predating the plant-animal divergence—capable of identifying candidate 
disease genes.  
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